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disinfected in the three solutions recommended by the Centers for Disease Control (CDC) as effective 
against the AIDS virus. The remaining three biprisms were disinfected by rubbing the biprism face with an 
isopropyl alcohol swab, a standard procedure in many clinical settings. The intraocular pressure 
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regimens influenced the results. At the time of measurement each biprism was evaluated to determine if 
any of the regimens affected the clarity of its front surface or the image of the Goldmann rings seen when 
performing the measurement. When comparing the clarity of the biprisms, those soaked in alcohol were 
found to be significantly different from all other groups, with all of the alcohol soaked biprisms being 
unusable after the fourth day. None of the other three disinfecting groups differed significantly from each 
other in regard to biprism clarity. Because the biprisms soaked in alcohol were unusable so early in the 
study, they were not used in the statistical analyses of lOP measurement and biprism image quality. No 
clinically significant difference was found in intraocular pressure measurements obtained with the three 
remaining disinfecting regimens of hydrogen peroxide, bleach and alcohol swab. When comparing the 
image seen while performing the Goldmann measurement, a significant difference was found between 
the hydrogen peroxide treated biprisms and those treated with bleach or the alcohol swab, with the 
hydrogen peroxide treated biprisms showing less image distortion. These results suggest that of the 
three disinfecting reigmens approved by CDC, hydrogen peroxide is the disinfecting agent of choice for 
the Goldmann biprism. 
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Abstract: 
Twelve new Goldmann biprisms were used to measure the 
intraocular pressure of the right eye of a single subject four times each 
day for fifteen days. Between measurements, nine of these bip~isms 
were disinfected in the three solutions recommended by the Centers for 
Disease Control (CDC) as effective against the AIDS virus. The 
remaining three biprisms were disinfected by rubbing the biprism face 
with an isopropyl alcohol swab, a standard procedure in many clinical 
settings. 
The intraocular pressure measurements obtained using the four 
disinfecting regimens were compared to determine if any of the 
regimens influenced the results. At the time of measurement each 
biprism was evaluated to determine if any of the regimens affected the 
clarity of its front surface or the image of the Goldm~nn rings seen 
when performing the measurement. 
When comparing the clarity of the biprisms, those soaked in alcohol 
were found to be significantly different from all other groups, with all 
of the alcohol soaked biprisms being unusable after the fourth day. None 
of the other three disinfecting groups differed significantly from each 
other in regard to biprism clarity. Because the biprisms soaked in 
alcohol were unusable so early in the study, they were not used in the 
statistical analyses of lOP measurement and biprism image quality. No 
clinically significant difference was found in intraocular pressure 
measurements obtained with the three remaining disinfecting regimens 
of hydrogen peroxide, bleach and alcohol swab. When comparing the 
image seen while performing the Goldmann measurement, a significant 
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difference was found between the hydrogen peroxide treated biprisms 
and those treated with bleach or the alcohol swab, with the hydrogen 
peroxide treated biprisms showing less image distortion. 
These results suggest that of the three disinfecting reigmens 
approved by CDC, hydrogen peroxide is the disinfecting agent of choice 
for the Goldmann biprism. 
2 
Introduction: 
Tonometry, the measurement of the pressure inside the eye, is 
routinely performed as one of the tests for glaucoma in optometric 
practices. The Goldmann tonometer is considered the standard 
instrument for that measurement.1 ,2 Because the Goldmann instrument 
requires corneal contact, it can be a potential source of viral or 
bacterial transmission from one patient to another.3,4 To avoid this 
transmission, some method of disinfection needs to be used on any part 
of the instrument that comes in direct contact with the eye. However, 
this disinfection process must not alter the surface characteristics of 
the instrument in any way that will be harmful to the eye or affect the 
accuracy of the instrument. 
With the discovery of the AIDS virus (HIV) in tears, the Centers for 
Disease Control (CDC) has issued guidelines for the disinfection of 
ocular instruments which involve direct eye contact. ~Three different 
methods are suggested by the CDC as effective against HIV. These 
methods require exposing the instruments to solutions of a) a 1 :10 
dilution of bleach, or b) 3o/o hydrogen peroxide, or c) 70o/o ethanol or 
isopropanol for 5-10 minutes.S All contact to no meters, including the 
Goldmann, are subject to these recommendations. 
The part of the Goldmann tonometer that comes in contact with the 
eye, the biprism, is not one piece, but is formed from multiple pieces of 
perspex, which is polymethylmethacrylate, glued together. Because of 
this construction, it is possible that the biprism, when exposed to these 
disinfecting solutiQns, may warp, discolor, or be damaged.6 This could 
affect the safety of the biprism because an irregular, warped or rough 
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surface brought into contact with the eye could result in corneal 
damage. The reliability of the instrument could also be influenced 
because the Goldmann biprism is designed to yield accurate readings 
when a diameter of 3.06 mm of corneal tissue is flattened by the front 
surface of the biprism. Any irregularity, warpage or roughness of that 
surface could alter the applanated area and potentially affect the 
intraocular pressure estimates. 7 It is the potential alteration of the 
biprism's front surface by disinfecting solutions and this alteration's 
effects on the intraocular pressure measurements or health of the eye 
that is of concern in this study. 
There is little in the literature regarding which solutions can be 
used on the Goldmann biprism for effective disinfection without causing 
damage to the biprism. The instruction manual for the Goldmann 
instrument directs the examiner to "clean the measuring prism with an 
aqueous solution of Pantasept 0.5% or a similar disinfectant that does 
not damage perspex (no alcohol solutions). "8 Pantasept is a 
concentrated glutaraldehyde solution which is included with the 
instrument when it is received from the manufacturer. Since it must be 
diluted to 0.5°/o for disinfecting the biprism and current literature 
suggests that a one hour exposure to 2o/o glutaraldehyde is needed to 
inactivate the AIDS virus, exposure to this O.So/o concentration is 
insufficient for disinfection. 9,10 Although the practitioner is warned 
not to use alcohol in the instruction booklet, one of the most common 
methods currently used for cleaning the Goldmann biprism is to briefly 
rub the front surface with an alcohol swab, and rinse it with distilled 
water.1 0,11 This procedure has not been proven sufficient to kill the 
AIDS virus and is not included in the recommendations from the Centers 
4 
for Disease Control. Those practitioners who are comfortable with this 
cleaning method may be unaware of the manufacturer's warning against 
alcohol and may choose alcohol soaks as the most convenient method of 
disinfection from those recommended by the Centers for Disease 
Control because isopropyl alcohol is quite commonly used on other 
instruments in optometric offices. Other practitioners, being aware 
that alcohol is not recommended by the manufacturer, will choose one 
of the other two disinfecting methods. Because all of the methods 
recommended by the CDC are effective against the AIDS virus, if one 
compromises the integrity of the biprism less than the others, it should 
be advocated as the disinfecting method of choice. 
A disinfecting method which is known to be effective against the 
AIDS virus should be used routinely because of the prevalence of the 
AIDS virus in the population, and the unproven, yet possible spread of 
the AIDS virus from contact with the tears. The AIDS virus has been 
isolated from the tears and conjunctival cells of patients with the 
syndrome.12, 13 It has also been shown that it can be cultured from high 
water content contact lenses worn by individuals with AIDS or AIDS 
related complex. In the study by Tervo and his associates, the AIDS 
virus was recovered from contact lenses containing 70o/o water from 
four out of .six patients tested, after 14-16 hours of wear.1 4 
There were 29,435 cases of AIDS reported to the CDC in the United 
States as of January 12, 1987. 89% of these cases were in individuals 
20-49 years of age. Of the cases reported in 1981, a 90% fatality rate 
has been documented.15 Because infection with the HIV virus is much 
more common than the reported cases of AIDS, it is estimated that 
500,000 to 1 million individuals in the United States are currently 
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infected with the virus.16 Many of these individuals have no signs or 
symptoms of the infection and are not aware that they are infected. 
Nevertheless. these people are carriers and can transmit the disease to 
others. probably throughout their lives. In a high prevalence area, the 
average practitioner could expect one out of every two hundred patients 
examined to be an HIV infected individuaJ.16,17 Added to this is the 
large number of ocular manifestations that will cause a patient with 
AIDS to seek optometric or ophthalmological help. These include 
diplopia caused by oculomotor difficulties, decreased vision due to 
cytomegalovirus retinitis, conjunctivitis, and Kaposi's sarcoma which 
often affects the eyelids and face.17. 1 8 
Because of the isolation of the AIDS virus in tears and conjunctival 
cells of patients with AIDS, 12,13 the prevelance of the undiagnosed 
infection,16,17,19 the ability of the virus to remain active for 3-7 days 
in the dry state,20 and the fatal nature of the disease,15,16 it is 
important that routine methods of disinfection of ocular instruments 
and contact lenses include methods which are known to inactivate the 
AIDS virus. Even though no proof of transmission by ocular instruments 
exists, both the American Optometric Association and the Oregon State 
Department of Human Resources, Health Division, sent letters to 
licensed optometrists and ophthalmologists reemphasizing the need for 
aseptic techniques and urging the use of the CDC guidelines for the 
disinfection of ocular instruments.21 ,22 This study was designed to 
determine if any of the disinfection methods suggested by the CDC had 
an effect on the reliability or integrity of the Goldmann biprisms. 
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Methodology: 
Subject: 
The right eye of one individual, in good health, with no corneal 
toricity, drug allergies, history of glaucoma, or other contraindication 
to the procedure was used for all measurements in this study. 
Procedure: 
Twelve new Goldmann biprisms were used to compare the routine 
method of cleaning the biprism against the three different disinfecting 
regimens recommended as effective against the AIDS virus by the 
Centers for Disease Control. Three biprisms were disinfected by 
soaking in three percent hydrogen peroxide, three in a 1 :10 ·aqueous 
dilution of household bleach, and three in 70o/o isopropyl alcohol. The 
remaining three biprisms served as controls and wsre cleaned by 
rubbing them with an isopropyl alcohol swab and then rinsing with 
saline, as is standard practice at Pacific University College of 
Optometry. Each of the experimental biprisms was soaked in the 
appropriate solution for two hours, removed from the solution, rinsed 
with distilled water, dried with cotton as recommended by the 
man ufacturerB, and visually inspected with the biomicroscope. The 
visual appearance and clarity of the front surface of the biprism was 
judged on the following scale: Grade 1: biprism clear at 30X; Grade 2: 
biprism hazing visible at 30X; Grade 3: biprism hazing visible at 15X; 
Grade 4: biprism opaque, surface rough or warped; Grade 5: biprism 
separated. If a grade less than 4 was found upon visual inspection, the 
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biprism was used in the routine manner to measure the intraocular 
pressure of the subject. After the measurement had been achieved. each 
biprism was placed in a fresh preparation of the assigned solution. This 
sequence was performed four times each day. five days per week for 
three weeks. In addition, four times each day, alternating with ttJe 
procedure described above, each biprism was removed from its solution, 
rinsed, dried and placed into a fresh preparation of the same solution. 
These conditions were designed to simulate the conditions of the 
biprism in a general optometric practice, with the practitioner 
performing tonometry on eight patients a day, five days a week. It was 
felt that most practitioners would leave the biprism in the disinfecting 
solution when not actually in use. 
When performing the measurement of the intraocular pressure, the 
following procedure was used. A biomicroscopic examination of the 
subject's cornea ·was performed to rule out any contraindications to the 
use of the Goldmann instrument. Fluress TM was then instilled in both of 
the subject's eyes and another evaluation of the cornea performed to 
make certain there was no corneal staining which contraindicated the 
procedure. Both eyes were anesthetized to decrease the subject's blink 
reflex even though all measurements were performed on the right eye of 
the subject. At each of four measurement sessions throughout the day, 
three measurements of the intraocular pressure were performed with 
each biprism. The biprisms were used in random order without the 
investigator knowing which biprism or method of disinfection was being 
used. This prevented investigator bias from influencing the results. The 
random order of biprism use also controlled the massage effect by 
preventing the same biprism from being affected each time. The 
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massage effect is a temporary decrease in the measurement of the 
intraocular pressure which occurs when aqueous is forced out of the eye 
by repeated tonometric readings_7,23 
As the intraocular pressure measurements were being performed, 
observations about the image quality were graded on the following 
scale: Grade 1: Image clear, ring pattern round, no focal irregularities, 
readings reliable; Grade 2: Image has indistinct borders, ring pattern 
round, minimal focal irregularities, readings reliable; Grade 3: Image 
recognizable, ring pattern elliptical, minimal focal irregularites, 
readings reliable; Grade 4: Image recognizable, ring patttern irregular, 
focal irregularities, readings suspect; Grade 5: Image unrecognizable, 
ring pattern too irregular to read. A grade of 5 precluded use of the 
biprism for further measurements and required an immediate evaluation 
of the cornea to insure no occurrence of corneal injury that might affect 
other biprism readings during that data-gathering period. All 
intraocular pressure measurements were recorded to the nearest one 
millimeter of mercury. After all measurements were taken, the eye 
was once again evaluated to confirm that no trauma had occurred. 
Apparatus and Materials: 
To increase the reliability of the measurements, the same 
Haag-Streit Goldmann apparatus mounted on the same Mentor 
biomicroscope was used throughout the experiment. The calibration of 
the Goldmann tonometer was checked each day by using the control 
weight as suggested in the instruction manual. 8 The standard procedure 
for performing Goldmann tonometry as written in Brandreth's book, 
Clinical Slit Lamp · Biomicroscopy 24, was used. 
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All twelve biprisms were manufactured by the same company, and 
were randomly assigned to a disinfecting regimen. 
Data Analysis: 
The data derived from day 1, when no disinfecting treatments had 
been initiated, was used to test for investigator consistency, 
consistency between biprisms, and subject consistency. 
To determine investigator consistency, a correlation coefficient 
was performed on the three readings taken at each measuring session 
for each biprism on day 1. The use of each of the twelve biprisms 
during the three measuring sessions on day 1 resulted in 36 groups of 
three readings each. High correlations between the first, second and 
third readings of each biprism at each measuring session would indicate 
that the investigator was consistent in technique and would allow the 
average of each probe's readings to be used for analysis. This was 
desireable because of the findings of Motolko, et al, whose results show 
improved reproducibility by averaging two or more Goldmann tonometer 
readings.23 
Consistency between biprisms was evaluated using a one-way 
analysis of variance on the average readings achieved with each biprism 
on day 1. No significant difference between probes would indicate that 
all biprisms are comparable and reliable at the start of the experiment. 
Subject consistency was evaluated using an unpaired t-test of the 
. data derived from day 1, once again when no disinfecting treatments had 
been started. This was done to determine if the order of biprism use 
and the potential lowering of the intraocular pressure with repeated 
measurements, discussed earlier as the massage effect, affected the 
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results. 
The t-test compared the first six intraocular pressure readings to 
the last six readings of each of the three measurement sessions. A 
t-test result of no significant difference would indicate that the 
massage effect was either not large enough to be of concern, or was 
compensated for adequately by the random order of biprism use in the 
experimental design. 
There are many other factors which may influence the intraocular 
pressure estimates found with any tonometer. These include but are not 
limited to diurnal variation, which is known to vary by as much as 2-5 
mmHg each day 7 • 25,26; caffeine consumption, or other fluid 
intake25,26,27; emotional tension7,25; and carotid compression} To 
attempt to compensate for these variations, the results of each biprism 
was averaged daily. 
This daily average of each biprism's findings was used in a 
one-factor analysis of variance. The F-test was used to determine if 
any significant differences between disinfecting regimens existed. If 
significant differences were found with the analysis of variance, a 
Scheffe test was used to find where the significance occurred. 
Nonparametric statistics were used to evaluate the changes in 
clarity and image quality of the biprisms. The Mann-Whitney U test, 
which is the nonparametric version of the two group unpaired t-test, 
was used for the statistical analyses of these data. 
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Results: 
Statistical analyses performed on the data derived from day 1, when 
no disinfecting treatments had been started, were designed to show 
repeatability of the investigator's technique, consistency between 
biprisms and subject consistency or adequate experimental design to 
control those variables which are not consistent. 
The correlation coefficient derived from the three readings taken 
with each biprism at each session on day 1 ranged from .839 to .904 
(Appendix 4}. These high correlations indicated good repeatability of 
the investigator's technique and therefore the average of each probe's 
readings was used for analysis. 
Analysis of variance on the mean readings derived from day 1 
(Appendix 4) indicated no significant differences between the readings 
taken with the twelve biprisms. This result indicates that all of the 
biprisms gave consistent and similar readings at the beginning of the 
experiment. 
A t-test was used to evaluate the massage effect by comparing the 
first 6 readings (E in Appendix 4) achieved at each measuring session, 
with the last 6 readings (L in Appendix 4) at the same session. There 
was no significant difference between these two groups. This result 
indicates that the massage effect was either not large enough to be of 
concern, or was compensated for adequately by the random order of 
biprism use in the experimental design. 
Based on the results of these analyses, it was decided that the 
experimental data were reliable and further analyses could be 
performed. 
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A one-factor analysis of variance was performed on the intraocular 
pressure measurements to determine if any of the disinfecting regimens 
affected the measurements achieved with each biprism. The alcohol 
soak regimen was not included in this analysis because of the rapid 
destruction of the biprisms. By the beginning of the fifth day of data 
collection, these biprisms could no longer be used to measure the 
intraocular pressure because ·of rough front surfaces which could 
potentially cause corneal staining and ocular damage. The rough 
surfaces appear to have been caused by weakening of the cementing 
substance used to fabricate the biprisms. The appearance of the 
Goldmann biprism after three days of the alcohol soak regimen alcohol 
can be seen in Figure 1 in Appendix 1. Note the early development of a 
rough anterior surface. 
Unlike those soaked in alcohol, the biprisms exposed to each of the 
remaining disinfecting conditions were all usable throughout the 
duration of the study. The daily average of the intraecular pressure 
measurements found with each of the re!Jlaining regimens are 
summarized in the table below and in Figure 1 in Appendix 3. 
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Daily Average of Intraocular Pressure Measurements 
Day H202 Soak Bleach Soak Alcohol Swab 
1 12.22 12.63 12.7 
2 12.36 12.39 12.81 
3 11.78 12.11 12.22 
4 10.50 . 10.61 10.31 
5 12.42 12.5 11.61 
6 11.86 11.86 11.19 
7 14.17 14.36 13.33 
8 12.94 13.94 12.5 
9 12.64 13.58 12.92 
10 12.36 13.17 13.19 
11 13.67 14.33 13.92 
12 12.78 12.28 12.81 
13 10.94 11.61 10.53 
I 
14 13.44 14.28 13.58 
15 13.61 14.64 12.36 
16 12.72 13.28 12.03 
Throughout the 16 days of data collection, the daily averages of 
intraocular pressure for the different disinfecting groups ranged from a 
low of 10.31 mmHg to a high of 14.64 mmHg. This is cr difference of 
4.34 mmHg. Considering the many variables which influence intraocular 
pressure, these results are reasonable for a normal subject.7,25,26 
When these intraocular pressure measurements were compared, no 
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significant difference was found between the hydrogen peroxide and the 
bleach treatments. or between the hydrogen peroxide and alcohol swab 
treatments. A statistically significant difference (p<0.05) was found 
between the bleach and the alcohol swab treatments, but this difference 
was not clinically significant. The mean of the alcohol swab treatment 
was 12.369 mmHg and that of the bleach 12.973 mmHg, resulting in a 
difference of only 0.6 mmHg. Since the Goldmann tonometer drum is 
marked in 2 mmHg increments and cannot be read with reliable accuracy 
to less than 1 mmHg, this is not a clinically distinguishable 
difference.2 8 
To evaluate the changes in clarity of the biprisms throughout the 
experiment the anterior surface of the biprisms was examined with the 
biomicroscope. All disinfecting groups were included in the statistical 
analysis which was performed using the Mann-Whitney U test. A 
significant difference was found between the alcohol soak and each of 
the other three groups (p<0.05). No significant difference was found 
between any of the other groups (See Appendix 4). A graphical 
representation of the changes in clarity found with each disinfecting 
group over time can be found in Figure 2 of Appendix 3. 
Photographs of the appearance of the front surface of the biprisms can 
be found in Appendix 1. Figure two is the appearance of the front 
surface of the Goldmann biprism when it is new and unused. It, and the 
photographs following it represent approximately 4X magnification and 
can be compared to each other. Figure three shows an alcohol soaked 
biprism at the end of week one. Note the loss of clarity of the front 
surface and the cough ring shaped area just inside the edge of the 
biprism. The results of three weeks of alcohol soak can be seen in 
15 
Figures four and five. The roughness of the front surface continued to 
progress with the addition of crazing of the deeper layers and 
disruption of the edge material. 
The biprisms cleaned . with the isopropyl alcohol swabs demonstrated 
some changes similar, although not as pronounced, to those changes 
noted in biprisms soaked in alcohol. The ring shaped area just inside 
the edge of the biprism which first became rough and irregular with the 
alcohol soaked biprisms, became mottled in appearance in the biprisms 
cleaned with the alcohol swab. This can be seen in Figures six and 
seven. The front surface of the biprism is seen in Figure six and 
represents a rating of three on the clarity scale used throughout the 
experiment. These changes did not seem to have any effect on the 
reliability of the readings achieved with these biprisms. 
The remaining two disinfecting regimens also resulted in clarity 
ratings of Grade three before the end of the experiment. The appearance 
of the front surface of the bleach and hydrogen p•roxide soaked 
biprisms at the end of three weeks can be seen in Figures eight and nine 
respectively. These two systems of disinfection did not seem to have 
any effect on the structural integrity of the front surface of the 
biprisms or the reliability of the measurement achieved with them. 
The image quality refers to the appearance 'of the rings seen when 
actually applanating the cornea. Because damage to the biprisms soaked 
in alcohol prevented them from being used after day four, they were not 
included in the statistics for evaluating image quality. A graphical 
representation of the change in image quality over time for the 
different groups can be found in Figure 3 in Appendix 3. As can be seen 
from the graph, the image quality of the biprisms soaked in hydrogen 
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peroxide is less distorted than the image quality of the other 
disinfecting methods. The image of the biprisms in the alcohol swab 
group had indistinct borders and focal irregularities, while the biprisms 
soaked in bleach had a blue glare present over all of the image seen 
through the biomicroscope. This glare decreased the contrast and the 
clarity of the ring image. The differences found between the image 
quality of the hydrogen peroxide and the bleach groups and between the 
hydrogen peroxide and alcohol swab groups were significant (p<0.05). 
No significant difference was found between the alcohol swab group and 
the bleach group. (See Appendix 4) 
Discussion: 
These results indicate that the disinfection of Goldmann tonometer 
biprisms by soaking in isopropyl alcohol should be avoided because this 
treatment destroys the perspex in less than five days; rendering the 
biprisms unusable. Wiping the biprism with isopropyl alcohol also 
produces similar but less severe changes and should be discouraged. 
Because of the similar results in intraocular pressure and clarity scale 
measurements when comparing the hydrogen peroxide and bleach 
disinfection methods, the quality of the ring pattern image seen with 
each of the systems becomes the differentiator for the method of first 
choice. As was previously mentioned, and shown graphically in Figure 3 
(Appendix 3), the biprisms soaked in hydrogen peroxide continued to 
provide a ring pattern image less distorted than the other disinfecting 
methods throughout the experiment. Because of this result and the 
equality of the other findings, the use of hydrogen peroxide is the 
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disinfecting method of first choice. 
It should be noted that all of the biprisms seemed to swell slightly 
after soaking. This did not seem to affect the intraocular pressure 
measurements achieved, but did make it difficult to insert and remove 
the biprisms from the holder. For this reason, it would seem prudent to 
soak each biprism the minimum amount of time necessary to achieve 
disinfection. 
The appearance of the biprisms soaked in hydrogen peroxide and bleach 
suggested that the haze was due to a deposit of material on the front 
surface. To test this hypothesis, after the completion of the 
experiment, one of each of the biprisms was cleaned with a hard contact 
lens cleaner, rinsed with distilled water and examined. The front 
surface showed a marked decrease in hazing for both the hydrogen 
peroxide and bleach soaked biprisms; however, the blue glare, noted on 
the biprisms soaked in bleach, did not diminish. 
Conclusion: 
Of the disinfecting regimens recommended by the Centers for Disease 
Control as effective against the AIDS virus, the method of first choice 
for use on the Goldmann biprism, as determined by this study, is soaking 
the biprism in a three percent hydrogen peroxide solution for 5-10 
minutes. 
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Appendix 2- Data Tables 
Data Day 1 - No Treatment 
Date May 25 1987 
Biprism No. 
' 1 12 13 14 IS 16 #7 #8 #8 #10 11 1 #12 
Crn. lntg.- Bfr: Clear Aftr: Clear 
Aeadinas 1 3 , 2 14 12 1 4 13 13 1 5 1 2 1 3 1 5 12 
tmmH_g} 13 12 14 12 14 1 3 1 2 1 6 13 1 4 14 1 2 
12 1 2 14 1 2 14 1 3 1 3 1 5 1 3 12 1 5 12 
Average 12.67 12 14 12 14 13 12.67 15.33 12.87 13 14.67 12 
Image Scale 1 1 1 1 1 1 1 1 1 1 1 1 
Clarity Scale 1 1 1 1 1 1 1 1 1 1 1 1 
Order of Use 7 9 4 8 2 1 0 1 1 1 5 6 3 1 2 
Time 6:00 Crn. Into.- Bfr: Clear Aftr: Clear 
Readi~ 1 3 1 4 13 1 4 1 2 1 2 13 13 13 1 4 1 3 1 3 
(mmHg) 14 1 3 1 4 1 4 1 3 13 12 13 13 13 14 1 4 
1 4 1 4 1 4 1 3 1 2 12 13 14 13 14 1 4 1 4 
Averaoe 13.67 13.67 13.67 13.67 12.33 12.33 12.67 13.33 1 3 13.67 13.67 13.67 
- t-- ~ Icc 
1 llll<Kia Qtociltt ,---- 1 1 1 1 1 1 1 1 1 1 1 
Claritv Scale 1 1 1 1 1 1 1 1 1 1 1 1 
Order of Use 9 2 11 4 1 2 1 8 5 3 10 6 7 
Time 9:15 Crn. lnt ~.- Bfr: Clear Aftr: Clear 
Readioos 1 1 11 1 1 1 1 10 12 1 1 1 2 1 1 1 1 12 1 1 
(mmHg) 12 1 1 1 0 1 1 1 0 1 1 1 1 12 1 1 1 1 1 2 1 1 
1 1 1 1 1 1 1 1 10 1 2 1 1 1 2 1 1 1 0 1 1 1 2 
AV$fe.Q8 11.33 tt 10.61 l1 10 11.67 11 1 2 1 1 10.67 11.67 11.33 
lmaoe Scale 1 1 1 1 1 1 1 1 1 1 1 1 
Claritv Scale 1 1 1 1 1 1 1 1 1 1 1 1 
Order of Use 1 7 6 1 0 8 1 1 3 4 1 2 2 9 5 
DAILY AVE. 12 .56 12.22 12.78 12.22 12.11 12.33 12.11 13.56 12.22 12.44 13.33 12.33 
GROUP AVE. 12.52 12.22 12.63 12.7 
-" 
Average 12.52 
Stnd. Dev. 0.475 
Data Day2 
L J Date June 1 1987 I 
.M f'rll.n 9:W( H202SOAK ,fi..EACHSC M ...... r"'UU"''' IWINJ 
BJJuiim No 1_1 1_2' 1 13 t 4 I • s r II 11 18 Jilt Jll t D II I fl12 
r I 
Time 1225 Cm. tnta.· Bfr: Clr Ahr: Clr 
_ReaditiQS 13 14 14 1 2 13 14 .4 12 13 l4 14 13 
_tmmHal 13 13 13 ,. 13 14 14 12 14 14 13 13 
1 4 14 13 14 13 14 14 12 14 1 4 13 14 
AV&f8fUj 13.33 13.67 13,33 13.33 13 14 1' 4 _l2 13 67 14 13.33 13.33 
rmage, scare 1 1 1 1 1 1 1 1 1 1 1 _t 
Cfarhv Scale t 1 1 , 1 1 1 1' 1 _t 1 1 
Older of Use 1 5 2 1 I 1 D 6 9 3 1 1 12 4 8 
-
Time 2:20 C:m rn•o,.- Bfr. C.r Ahr= Clr 
Readnas 13 13 14 14 13 14 14 , 2' 14 13 14 14 
JmmHgl 14 12 14 14 13 14 1.! 12 14 14 14 14 
14 I 13 13 14 13 , .. 14 12 13 14 14 14 
Ave~a~e 13.67 12.67 13.87 14 13 14 14 12 )_3 .. 87 13.·67 14 .14 
I 
tmaaesca 1 , 1 1 • I 1 t 1 1 
, 1 
_CJariiY Scare 1 1 1 1 t 1 1: , 1 1 1 I 
Order of Use 2 5 11 3 4 7 1 0 9 7 12 1 e, 
Time 4:35 Cm. In g.- Btr.:- Clr Ahr: Cll_ 
14 12' 14 12 10 12 12 1 0 12 1 2 14 12 
fmmH~d 14 '11 13 12 1 0 12 12 10 12 12 14 12 
,~ 11 hi 12 10 11 1 3 tO 14 12 13 12 
Avera.J~G 14 11_. 33 13.67 12 10 11.67 12.33 1 0 12.67 1 2 13.67 12 
~ 
!~Seale 1 1 ~ 1 1 , 1 1 1 1 1 1 
Olal'itJ Scale 1 11 I 
' 
l 1 1 I 1 1 1· 1 t 
Ordet.af Usa 4 1 0 ., 12. 8 8 5 , a 2 7 I 9 
Time 6:45 Cm. lnlo,· Bfr: C!r Aftr. Clr 
,,.. ~. 1 I 13 1:2 t 1 10 12 12 1 1 t1 j _1 10 13 
hnmH_g) 12 13 1 2 u _10 J 2' 1 2 11 1J_ .10 1 t 12 
12' 12 12 12 10 12 12 \2 11 11 1 ' 12 Ave~aae t 1.8_1_ 12.8J 1_2~ 11.39 Ul 1 2 1 2 11.33 t ] 10.:.87 10.87 12.33 
lmagaScara 1 1 1 1 I 1 1 1 t 
' 
1 I 1 
C:larilv scale. 1 1 t I 1 1 1 1 1 1 1 1 1 
Order of Us:o 15 1 I 3 9 I 12 7 6 1 0 11 ~ 8 2 
I I 
DAILY AVE. 13.1 7 ,2.58 13·.11 12.67 11.5 12.92 13.08 11.33 12.75 12.58 12.92 12.92 
GFO.PAVE. 12.91J 12.36 12.39 I ,2~81 
I 
C.ommel')1s: I i 
Data0ay3 
I I Date June 2 1987 I I 
.IIi" 'l""U"'f SC'.W( _,202SCWC EI.EACHSJAK .ALCOI<l.f!NINJ 
Biorism No. 11 tll 13 •• I 5 -~ •s 
_, 
_ _, 8 II_ lj 0 ., 1 112 
' 
I 
Trm,e 11:45 C.rn. Jnt!'J.· Btr: Cit A{Lr. Clr 
Readings 12 12 t 1 13 12 12 1 A· 1 2 14 12 12 12 
lmmHa~ 1 3 13 1 2 13. 12 12' 13 12 1-f 13 12 12 
14 ., 2 12 12 11 1 2 13 12 ,. 13 12 12 
Averaoe 13 12 33 1 1 •. fH , 2.67 '1.87 t 2. t3.33 12 , ... t2.67 12 12 
• rtnaH_ Scale 1 11 1 1 1 1 1 1 , 1 1 1 
ClanllY ScaJa 2 1 + 1 + 1 1 1 1 1 • 1 , I 1 
OlJSt;lr ·of Use 4 1 0 1' 1 6 _2 9 s 3 1 7 t2 B 
Time' 1:35 Cm. Jnl:m,· Bfr; Cir Aftr. Clr 
Aaidi'KI$_ 12 13 12 10 13 12 12 
-
11 13 11 t3 12 
JmmH_a) 1 1 12 11 _10 _13 12 12 1 t 13 tt 13 13 
1 0 12 13 10 12 ,. 12 \2 13 1 2 1, 3 13 
Ave~aqe 11 12.33 12 10 12.87 12.87 1 2 11 .33 1S 11.33 13 12.67 
Jn;age Scale 1 , 1 1 1 1 1 1 1 1 1 1 
Clarity scare 1 + 1 + J+ 1 1 t , 1 • 1 , 1 1 
Older of Use 7 10 2 11 5 6 1 3 12 8 1 1 .. 
lime 4:10 ern. rnrg.· Brr: Clr Aflr. Clr 
Read'll'!m:_ 12 13 12 ~ tO 13 12 12 1 1 13_ t1 13 12 
(mmHg) 1 1 ~2 11 1 D 13 _t2 _12 1 I 19 1_1 13 13 
1 0 12 1 3 10 12 14 12 12 13 \2 13 1 3 
AV8ii'3oe 1 1 12.33 ' .2 to 12.67 12'.67 12 11.33 1 3 r 11.33 13 1,2'.6•7 
JmageScale 1 1 1 1 1 _1 , t 1 1 1 1 
Clarity Sc~e , + 1 + 1 + 1 , 1 1 t • 1 1 1 1 
Ordet or Use 8 4 e I I 3 9 1 2 5 7 10 2 11 
' 
'Tim.e 6~.20 em. fn1Qi. 6 9ft: Clr Ar_lr: Ctr 
1~. • .n- 1 3 1 0 1 2 12 10 12 1 I 12 11 t2 10 1 3 
(mmHgl 13 
' 
1 0 13 12 12 1 • a 1'1 1 1 1 2 t 0• 14 
13 1 0 12 13 1 1 I 01 11 12 12 14 ., Q 13 
AveiiJge I 9 10 12.33 112.93 . 1 , 11 f0.33 11.67 , 1.33 t2.f:l7 to 13._33 
. I 
lmamtScale 1 1 ; 1 I 1 1 1 1 t 1 1 1 
Clarity Sea e 1 1 + I 1 + 1 + 1 1 11. 1• ,._ , 1 1 
Order of Use 4 1 2 I 1 s 3 7 8 , 1 1 0 2 9 6 
D~LVAVE. 12 11_._75 -1 12 11.25 12 12.08 11.92 t 1.58 12.83 1 2 12 1_2.6? 
GR:IJPAVE. , 1.92 i 11.78 12.\1 12 .22 
~ 
Comments:: • Two? aruas ... crvstallization of __gjue @ 180 
+ O_paquuTua 380° 
Oata0ay4 
r l Dorl.e June 3 1987 I 
AI..CXHl...S WI ~202SOAK ELEACH'SOAK Mrn.n 9NNJ 
iJbnism No. 11 12 13 14 :1 s I il6 17 18 ID IJ. 1 0 111 .,2 
I 
Time 1 ':so ern. fnl!k BJr: Clr Altf: Cllr 
' 
I Re;sdinas, 1 0 12 12 12 I 1 0' _1__2 1_2_ 11 12_ 1 1 12 12 
t_mmHal , 1 11 10 ·t 2 10 12 12 11 12 11 12 10 
10 10 10 13 10 11 1 , 12 1 , 12 12 11 
Ava_@Qe 10.33 11 ' 10.67 12.33 10 11.67 11,67 _11.33 11.87 1_LS3 12 1 1 
tmaMScala 1 1 1 1 1 1 1 1 J. 1 1 I 
Clarity bfe 
' + 
1 + 1+ , 1 , .. 1 ... 1 .... 1 , 1 ... ,_ 
O.:deror Use 8 2. 9 _3 _]Q 
' 
4 7 12 B I 11 5 
I 
' 
Time 2:00 Crn. In a.- &tr· ctr Aftr: SPK anesthetic} 
Audinas 10 12 N=l 10 10 10 10 12 9 10 1 0 1 a 
_l_mmH!U 11 ' 1 3 tliR 10 1£1 HI 1 0 12 10 11 1 0 I 10 
11 1 3 ~ 11 9 11 1 0 12 10 1 I 10 1 1 
Avet:aQe 10.67 12.67 10.33 9.667 10.33 JO 1 2 9. '667 10.67 1 to 10.33 
JmMaeScal~ 1 din 1dim :1 , 1 1 1 1 1 1 1 1 
Cl~arilv Scale 1 + 1 + 4+ 1 2 2 .. 1- 2• 2 2 1- 2-
Older or use 7 s 2 8 4 10 t1 3 1 12 9 s 
T.ime 4:10, ... Crn. rn~o.- Bfr. Clr Aftr: Clr 
Rs3dinos 10 tEt ~ 9 10 I , 0 9 12 10 tO 1 0 
"· 10 1\R 
'*' 
10 10 10 10 8 1 , • 9 1 0 . I 1 ... ~ I 1 to to 10 9 I 12 1Q 1 0 9 
Ava~ 10.33 10 10 9.687 , D 8.667 11.6-7 9.667 9.667 9.867 
' 
lmaoe Scal8 1 1 1 1 1 1 1 1 ' 1 1 
Cluilv Scale 1+ 4+ 4+ 1 2- 2 .. 1- 1 .... 1 f , .. 2· 
Order of Use 6 5 I 8 10 2 7 
' 
1 1 3 9 4 12 
nme 6~:10 Cln. ln1a.~ ar,: Clt Artr: Cl1 
Re~ 
-
1 0 t.R ~ 8 1 1 12 9 11 10 10 10 9 
(mmHgl 10 ~ t-A 9 11 12 9 11 ' 10 9 1 0 1' 0 I 
I 9 tt::t N=l 10 1' 0 13 10 1 I 1 I 10 10 110 
IAVBfaoe 9.667 '9' 10.67 12.33 9.333 11 10.39 9.667 10 9.667 
' ~nwt.a Scale t J. 1 1 1 2 t 1 1 1 
Ctari~ Seale: 1 i' 4+ 4+ 2 2 ... 1- 2- 2·· .. 2 2 .. 2 .. 2- I 
Order of Use g 5 4 I 1' 8 2 8 1 1 12 7 3 10 I 
DAILY AVE. 10.:25 10.42 101.08 1 1 10.25 10.75 10.83 10.33 10.42 10.1 7 
GFIJI.PAVE 10.76 10.5 10.61 10.31 
' 
Co.IMients: • Two? areas I ~ crvs~llizaJion of Q1lue @ 180 
+ Oca~C~c\18 glue 3&o• f 
Data DayS 
I I Date June 4 1987 I 
ALOOI-OL~ H202SOJ! K El.EACH SOAK Al..CX)H(l_ SW/la 
Biprlsm No. # 1 #2 #3 # 4 I # s #6 #7 #8 #9 #10 # 1 1 #12 
t 
Time 12:50 Crn. ln!CI.· Bfr: Clr Aftr: Clr 
1Rtaadinas fiA ~ ~ 1 1 11 9 9 1 2 1 1 11 10 1 2 
1 (mmHa> fiA t-.R t-.R 1 1 10 10 1 0 12 1 2 10 9 1 2 
t-.R t-.R t.A 12 9 10 1 1 11 12 9 1 0 1 1 
Averaae 11.33 10 9.661 10 11.67 11.67 10 9.667 11.67 
lmaaeScale 
' 
1 1 1 2 2 2 2 2 2 
Clarity Scale 4+ 4+ 4+ 2 2 .. 2 .. 2 .. 2 .. * 2 1 2 .. 1 .. 
Order of Use 10 ~ 1 1 2 9 1 1 7 8 4 3__ s 6 2 
Time 3:00 Crn. lntg.- Bfr: Clr Aftr: Clr 
Readinas t\R t\R t-.R 1 2 12 11 12 11 9 10 9 10 
_tmmHru Nt m N=\ 12 11 11 11 1 2 1 1 11 8 8 
t\R t-.R t-.R 1 1 1 1 10 1 3 9 9 9 9 8 
Averaaa 11.67 11.33 10.67 1 2 10.67 Q.A67 tQ_ 8.667 8.667 
baQeScale 1 1 1 2 1 ~ 2 2 2 
iCfaritv Scale 4+ 4+ 4+ ~ 2 .. 2 .. 1 .. 3 .. * 1 .. 1 2 .. 2 ... 
liCDrder of Use 8 9 1 1 2 3 6 10 4 1 12 7 5 
Time 5:00 Cm. __ lota.· Bfr: Clr A tr: Clr 
AeadinQS" m m fiA 1 4 1 6 14 15 1 6 17 16 1 4 1 6 
' fmmHal Nl m tfl 1 4 1 5 1 4 1 6 1 6 1 7 1 6 14 1 6 
fiA t\R t\R 1 5 1 6 14 1 7 16 1 7 1 6 1 6 1 6 
Averaae 14.33 15.67 14 16 16 1 7 1 6 14.67 1 6 
lmaaeScale 1 1 1 2 2 2 2 2 2 
Clarity Scale 4+ 4+ 4+ 2 2 .. 2 .. 1 .. 2 -· 2 2 2 ... 1 .. 
Order of Use 10 3 7 2 5 1 11 6 1 2 9 4 8 
Time7:00 Crn. lntQ.· Bfr: Clr Aftr: Clr 
Readings t\R t\R t-.A 12 1 4 1 4 1 2 1 4 10 10 13 I 1 0 
1mmHg) t\R t\R t\R 1 4 13 1 4 1 2 1 2 1 0 1 0 13 1 0 
t\R t\R t\R 1 3 1 3 1 4 12 1 3 1 1 1 1 1 4 1 1 
Averaae 1 3 13.33 14 1 2 1 3 10.33 10.33 13.33 10.33 
lmaaeScale 1 1 1 2 2 2 2 1 2 
Clarity Scale 4+ 4+ 4+ 2 1 ... 2 .. 1 .. 2 ... 2 .. 2 2- 2 .. 
Oniler of Use 9 1 0 2 8 1 5 6 7 11 4 3 1 2 
~ 
DAILY AVE. 12.58 12.58 12.08 12.5 12.83 12.17 11.58 11.58 11.67 
GFOJPAVE. , 2.42 12.5 11.61 
\ 
Comments: • Two ? areas . - crystallization of alue @180 
+ Ooaaue alue 360° 
Oata0ay6 
I Data JUM 5 1987 I 
ALOO-D..OOAK H202SOAK ll.EACH SOAK AUX:H::l.SWAB 
Ellortsm No. 11 1'2 113 I 4 ~ il 5 I •a 17 18 ID ItO 1 11 112 
~ 
' Time 1:00 Cril'l•. tn1a.• Bfr: Cl, Afrr: Clr _Read~ r.R NFI l'f' 14 15 13 J4 1 5 19 1 2 1 2 1 4 
(mmHal N=l tEt tA 14 15 15 1 5 15 1 7 12' 13 14 
... }.A toR t3 I 1 5 1.C I 6 15 17 13 13 14 
Av~ 13.67 15 1 4· '5 15 18.67 12.33 12.67 14 
llrnaae Scala 2 , 1 2 1 2 2' 1 ~2 
C'adty Scale 4 4 4 :2 .. 2 2 2'- 2 .. • 2- 2- 2- 2 .. 
Orda1ofUsa 7 2 12 
" 
3 4 (I 11 I 5 8 10 
IIlma 9;00 Cm,, lntg,- Bfr! Cfr Afar. CJr 
ReadlKI$_ ~ N:t IIA 12 13 13 1 1 1 1 12 _12 12 10 
fmmHa) lfi t.ft ~ 12 13 13 11 1_1 t2 12 12 12 
tit t.R N=l n 1 2 13 1 2 I 1 13 1 2 12 1.2 
Ave~, 1 t.67 _12.17 13 11.33 1 t 12' 33 12 12 11.33 
l~Scalo t 1 1 2 1 2 2' , 2 
Cladtf_ scare 4_.t_ 4+ .... 2- 2 .. 2- 2- 2 -· 2- 2- 2- 2• ... 
O~rofUse, 7 1 0 9 8 2 
' 
6 5 4 12 1 1 3 
--
Tima S:OO Cm. lnla.- Bfr. CIT Afu: Clr 
RBadlnQSJ ~ I tEl ftA 9 t 1 8 ., 10 10 1 0 7 9 
~·mm'Hal ... ~ ~ 10 11 8 7 tO 1 D 1 0 6 10 
N=l ~ N't' t 01 1. 0 9 7 '11 1 0 9 7 10 
Average 9.867 I 0.87 8.333 7 10.3·3 10 9.6B7 6 .667 9 .667 
lrnago Scale 1 1 1 2 1 2 2 2 2 
CiariiY Sc•da 4+ 4+ 4+ 3- 2 .. 3.• 2- 2 ... 2 ... . 2 ... 2 .. • 2~· 
Orde·r-of Use 11 3 g 10 5 1 2 2 8 1 6 '1 4 
Time 7:0D Crn. rn a·.- Brr: Olr Af1r. Cft 
Readio!:ls ~ Nl 
"" 
t1 I 1' 0 1 2 1 1 12 10 12 12 10 
fmmHal .t--R Nil Nl t2 1 0 12 1 1 1 3 1D 12' 1 2 1 0 
t.A N=t N"r 12 1 0 12' 1 1 13 '1 D tl 12 10 
AYemi.Ell l1.67 1 ,Q 12 11 j2.67 10 1 2 12 1 0 
-
Image Scale 1 1 1 2 2 2 2 2 2 
Claritv Scale 4-t I 4+ 4+ 3- I 2• 2- 2 .. 2- .. 3- 2 .. • 2-· 2 ... 
Older of Use 3 7 2 8 4 11 6 9 12 1 0· 5 1 
DAILVAVE. 11.67 12.08 11.83 11.08: 12.25 12.25 11' .s '1 0.83 11.25 
GR::ll.l? AVE.. - 11 .8& 1, .86 11.19 
Comments= • Two? areas .. CHstallization of .glue @180 
+ Opaaue glue so- I 
Data Day 7 
I nat• Jvn• a 1987 I I 
M ........ ECW( .~ aotSOAK ~SOAK .AUXlH:I.&NN3 
BiDrism No• ,, •2 13 lt4 J5 16 17 iB •• 110 
.,, 1_12 
Time 9:30 Ctn. ln~g .• Brr: Clr Ai1r: Clr 
A&adnas N=l ~ N=t 14 12 ,, 13 1 .. H 18 .12 14 
fm.mHa~ fA p.fl ~ t2 12' 1 4 13 141 1i 12 1' 1 ,. 
~ m 1-.A 13 12 15 14 13 15 12 to 14 
Awraa.e 1 a 12 14.33 13.33 13.67 15..{7 12.33 11 1~ 
ImaGe Seafe, 1 , 2 2 2 2 1 2 , 
cramv Scale 4+ 4+ 4+ 3-. a ... 2- 3 .. 3-· 3· S• a-• 2-· 
O«kkr of Uu 9 11 1 0 12 7 1 :2 9 
' 
8 8 5 
II~m• 11:to ~- tnta.· Bf1: Clr Af r: Clr 
t..R ~ til 16 _1& 15 15 15 11 1 5 , 5 , .. 
,(mm~l fiFII bR 11Ft Ul 15 15 16 15 111 1S 15 14 
~ ~ ~ 1 6 1 6 18 •s 15 11 15 16 14 
Ayar~ 1 I 15.33 15.33 15..3.3 15 11 I 1 5 15.39 14 
I~ &ala I I I 1 2 2 2 2 2 2 
CIQI11v Seattl 4+ 4+ 4+ 3 .. , .. 3- 3'• 3 .... 3- 3- 3-· a .. • 
Order of Use 1 12 7 Q 3 2 6 5 ,. • 1 0 8 
Tbne 1:10 Cm. lntn.- Bfr.: Ch' Aflr. Clr 
~-- N=t t.A Nl 1 7 15 15 14 16 u 
,, , 4 14 
fmmHQ} N=t N=l ~ 17 ~ 14 1 5 14 17 1 5 1 5 I 13 1~ 
"" 
IIR tiFl t6 14 1 5 15 1 6 16 15 15 14 
Averaae 16.67 1<4 .33 15 14.33 16.33 1543 14.67 14 14 
ftnaqe Scale 1 1 1 2 2 i 2 2 2 
CtarUv Scale 4+ 4+ I 4+ 3- 3 ... 3- 3- 3-· 3· s.-• a-• 3-· l 
-Otda1 ol Use 1 I 9 4 5 J' 1 2 1 0 a 6 8 2 7 
T(MS 3:20 Crn. lnra. ~ Bfr: Clr Aftr. Clr 
Readinos ~ ~ N=l 10 , 5 12 12 1 41 ,. 12 1 0 13 
lmmHa) N=l '*I 1-.R 1 1 I 1 s t2 12 14 , . \2 11 1 3 
m I'R riA 1 D I 6 13 t2 1 s, 1 • 12 12 12 
4V81i~ 10.39 15.33 12.33 12 14.33 , I • t2 I 1 12.67 
I I 
lmat~e' Scale ·t 1 t 2 2 2 1 2' 2 
Cihari~ Scale 4+ 4+ 4+ 3· 3· 3· 3- 3 ... 3· a- 3-· 3-· 
Order of Use 3 11 0 9 . 7 5 8 1 4 12 2 1 1 8 
DAILY' AVE. 1 4 1'4.25 14 .25 ,3.75 14.83 1.t 5 13.5 12.83 13.67 
CR:ll.PA\£ 14.17 14.3& 13.33 
Comments: • Two ? areas .. CJli.Stallization of glue _@~180 
.+OpaQue glue 3600' I I 
Oata0ay8 
I I Date June 9~ 1987 1 
AL<XH:x.OOAK H202SOAK BlEACH SOAK AL.<XH:x.SWM 
BiPrism No. , 1 12 t3 t4 • 5 r t6 #7 #8 #9 110 111 #12 
' Time 9:15 r I Crn. lntQ.· Bfr: Clr Aftr: Clr Readings NR N3_ t..R 1 4 14 1 5 1 5 1 4 1 4 1 4 1 1 1 2 
_lmrnl:i'g,. _N:t N=t ' ~ 14 14 15 1 6 14 1 5 14 12 13 
~ tfl tfl 14 14 1 4 16 1 5 15 15 1 3 12 
A~ 1 4 14 14.67 15.67 14.33 14.67 14.33 1 2 12.33 
' 
-
I~ Scale 1 1 1 2 2 2 2 2 2 
ClaritY Scale 4+ 4+ 4+ 3- 3- 3- 3- 3-· 3- 3- 3-• 3-· 
Order of Use 5 6 8 7 1 1 1 4 9 12 2 3 10 
Time 11:20 Crn. lnta.- Bfr: Clr Aftr: Clr 
, ...... .L ftft ~ m 12 12 12 12 12 12 13 12 10 
fmmHc:ll t-R I 
'*' 
m 13 12 13 13 1 1 12 13 1 2 1 1 
tfl 1*4 ~ 12 12 12 14 13 13 14 12 12 
Average 12.33 12 12.33 13 12 12.33 13.33 1 2 1 , 
lmaaaScale 1 1 1 2 2 2 2 2 2 
Claril¥ Scale 4+ I 4+ 4 + 3 - 3-- 3 .. 3- 3-. a .. a- a-· a-= 
Order of Use 5 I ,a 6 1 0 11 4 2 3 1 12 7 9 
Time 1:ao Crn. lnta.· Bfr: Clr · Aftr: Clr 
Readilg f\R Nol tfl 13 t4 14 1_$ 1 4 1 6 12 14 1 4 
tmmHal m N-1 ~ 1 3 15 14 1 5 1 5 16 13 14 1 4 
t-R ~ ~ 12 16 14 15 1 5 16 1 3 14 14 
Averaae 12.67 15 14 1 5 14.67 1 6 12.67 14 1 4 
lmaaeScale 1 1 1 I 2 2 2 2 2 2 
Claritv Scale 4+ 4+ 4+ a .. 3 .. 3 .. s .. 3 .... a .. 3- a-• 3-: 
Order of Use 9 6 7 1 2 s, 2 1 1 5 1 10 8 4 
Time a:15 Crn. lntQ.· Bfr: Clr Aftr: Clr 
Readii'IQS t-Il fill: N=i 10 10 14 15 1 2 1 3 11 1 0 12 
fmmHQI) t-R ~ m 1 0 j , , 13 , s 12 1 a 11 11 13 
t-.R 
'*' t..R 11 10 
' 1 4 1 4 1 1 14 1 1 1 1 1 3 
Averaoe 10.a3 10.33 13.67 14.67 11.67 13.33 11 10.67 12.67 
I tmaaa Scare 1 1 1 2 2. 2._ 2 2 z 
Claritv Scale 4. • 4+ .... :t- 3· 3• 3- 3-· a .. a .. a-• a~= 
Order of Use 9 8 , 2 a 7 11 4 6 1 5 10 2 
I 
DAILY AVE. ' 12..33 12.83 13.87 14.58 1a.17 14.08 12.83 12.17 12.5 
GR:lUPAV£ 12.94 1a.94 12.5 
Comments: • Two? areas - crysrarlization of atue @180 
+ Opaa.ue glue 360° I 
Oata0ay9 
I I Date June tO~ _1987 
W< IUUD..SC H202SOAK BL.EAa-1 SOAK Al.c;a.a_ fNJNj 
BIPrism N_o_. 11 12 13 ... '5 I t6 17 t8 #D -1 D 111 il12 
I 
-
Time 8:30 ' Crn. ln1a..:- Btr: err Artr: Clr 
Re,adlnas riA tf:l lfl 12 , 1 1' 3 12 ] 6 12 1 4 
' 
13 1 4 
ftnmHa) N:t N=l N"t 1.2 12 13 12 _16 14 14 14 t 3 
ttFt ~ m t3 12 12 13 ts ·~ 14 13 1 5 A "Varma 12.33 11.67 12 67 12'.33 15.67 13.33 14 13.33 14 
Image ScaJie 1 1 t 3 3 3 2 2 2 
Claritv Scale ol+ 4+ .t+ 3- 3 .. 3- 3, .. 3 ...... s-•· s-• _, ... 3 .. • 
Order at Usa 11 1 9 2 4 8 8 5 10 12 3 7 
Tlm_a 11:00 Ctn. Jn a.- Bfr. CJr Aft: Clr 
Raadiras ~ fEt tEl 16 14 1~ 13 1 3 15 14 14 15 
(mmHal m N=l N=t t6 14 14 13 1A , 6 15 14 16 
~ m 
'*' 16 15 14 13 ~4 16 , 5 14 1 5 Average HI 1' ~33 14 13 13.67 15.67 U.67 14 15 
lmaaeScafQ 1 1 , 3 2 3 2 2 2 
craritl_ Scale 4+ 4+ 4+ 3• ,s ... a ... 3 .. a-· s-• 3·· 3-· 3-"' 
Ckde_I_:Oj Use 5 3 I , 1 2 g, t2 1 8 HI 4 6 1 
Tima 2:3D C_m. lnlg,- Btr: Clr Ahr. Clr 
Readinas t.R_ t.A Nl 1 1 13 11 1 4 1 3 1 4, 12 12 13 
tmmH_a.) Nl f.A N:t 12 13 12 14· 14 15 12 13 13 
~ tEi t.A 18 12 12 14 14 1 5 13 1 1 13 
Averaae 1:2 12.67 11 .. 67 14 13.67 14.61 12.33 12 13 
'-
lm~Scal'e I 1 1 1 3 3 3 2 2 2 
c~scara 4+ ~>4 + 4+ , .. 3- 3 .. 3- 3 ... s-• 3-· 3-• 3-o 
Older of Use 9 5 6 1 1 8 3 2 10 4 12 1 1 
Time 4:30 Crn. lntg_.- Bfr: Cfr Artr. Ctr 
Readtms ~ N=t tf:l 11 12, 12 1 2 1 4 , 1 11 10 1 1 
_lm~!l'l ,.,:t ~ m 11 12 11 12 14 -11 12 11 10 
~ N=t PIA 12 1 t 11 '2 1 4 , 1 t 1 11 11 
Aveta_p 11.33 '1.87 '1 .S3_ t 2" j_. 11 u.sa 10,87 10 .161 
lm8fi~Scale 1 1 t 3. 3 3 2 I 2 2 
Ctaritv Scale 4+ 4+ 4+ 3~ I 3- a, ... 3~ a.-. 3 ... 3·· 3-"' 3-c 
OldarofUse s 3 1 2 9 1 0 4 
-'· 
6 1 12 1 1 
DAILY AVE. 12.92 12.58 12.42 12.83 14.25 13.67 13 .·08 12.5 13.1, 
GFO:JP AVE.. 12.64 13.58 12.92 
Comments; • Two? aMas .. CIYslallizatiGn of_Alua _@_1 80 
+ ~Opam,~e gtue 360° 
Data Day 10 
J Date J"ne 11 1987 I 
AL.CXKX.~ H202SOAK Rl !::AN-I SOAK ALOOHOLSWNJ 
BiPrism No. # 1 # 2 I • a #4l#5 l #6 #7 #8 #9 #10 #1 1 112 
I r 
Time 9:30 Crn. lnta.· Bfr: Clr Aft: Clr 
Readiogs toft NR toft 1 3 1a 1 4 12 1 4 1 4 1 2 1a 1 5 
_[_mmHol toft 1\ft t-,R 1a 1a 
-
14 13 14 14 12 14 1 5 
t-.R t-,R l'.fl 1a 13 1 4__ ta t 4- t4- 1 1 14 1 5 
Averaae 1a 1 3.__ t4 12.67 14 1 4 11.&-1 1a.67 1 5 
lmaae Scale 1 1 1 a 2 2 2 2 2 
~!tv Scale 4+ 4+ 4+ a .. a .. 3 ... 3 .. _a_ ... 3 .. 3-.,. • a .. • a .. • 
Order of t:Jse t2 2 4 5 9 6 8 1 0 1 1 1 a 7 
Time 11 :30 Crn. lnta.· Bfr: Clr Aftr: Clr 
Readings l'.fl t-.R t-.R 15 14 1 5 1 5 1 5 16 1a 14 16 
(mmH!l) N=\ N=\ N=\ 1 5 1 4 1 5 1 6 15 1 6 1 4 ' 1 4 16 
I Nt· N=t fR 16 j .A__ _1_5_ f- 1--6-- 1--6-- 1--5- r--- ·t-4- 14 16 
- r'\~CI!Oe 15.a3 1 4 1 5 15 6.7 15.33. ,_5~6.7 l3Al1 14 1 6 
' . 
lmaoeScafe 1 1 1 .a. 2 2 a 2 2 
Clarity Scale 4-+ 4+ 4+ a .. 3 ... a .. a- a .... a .. a .. • a .. • a .. • 
Order of Use 12 6 1 1 a 1 0 1 5 2 4 8 9 7 
t--
Time 1:ao Crn. lntQ.· Bfr: Clr Aft: Clr 
Readif'IQS t-,R N=\ t-.R 10 8 1 1 1 0 1-1 14- 1- 2 14 1 2 
- Nf Nl ~ 1 1 10 1 1 10 10 14 1 a 1 4 12 
l'.fl t-.R 1\ft 10 11 1 2 11 12 14 14 1a 1 2 
AveriMte 10.aa 9.667 11.aa 10.aa 1 1 14 1 a 1a.67 1 2 
~ 
Jmaae&al& f 1 1 3 3 2 2 2 2 
C-laritY Scats 4+ 4+ 4+ a .. a .. a- a-- a .... a ... a .. • a-• a .. • 
Order of Use 2 8 6 9 5 1 2 7 1 a 11 4 1 0 
Time a:ao Crn. lnta.- Bfr: Clr Aftr: Clr 
Readings t-,R t-,R t-.R 1 0 10 1 2 12 1 1 1 1 1 0 1 2 1 3 
CmmHg) NR t-.R t-.R 1 1 1 1 , 0 1 2 1 1 1 2 1 0 1 2 1 4 
NR t-.R t..R 1 2 1 0 12 1 a 1 2 1 2 10 1 a 1 3 
Averaae 11 10.a3 11.3a 12.a3 11.33 11.67 10 12.33 13.33 
lmaaeScale 1 1 1 a 3 2 2 2 2 
Clarity Scale 4+ 4+ 4+ 3 .. a .. 3 ... a-- a .. • a-- 3-· 3--· a .. : 
Order of Use 2 1 7 11 4 3 9 1 0 5 1 2 8 6 
DAILY AVE. 12.42 11.75 12.92 12.75 12.92 13.83 12.08 13.42 14.C 3 
GR:XJPAVE. 12.36 1a.17 13.19 
Comments: • Two? areas .. crystallization of glue @180 
+ Opaaue alue 36o• I 
Data Day 11 
l I Date June 12 1987 
.Al..CXlH:X. OON( H202SOAK IUACHSOAK Al..CX:)H1~ r.INJ 
BiDrism No. # 1 #2 #3 14 I 15 1 #6 #7 #8 19 110 11 1 #12 
I I 
T1me 12:00 Crn. l~tg_.- Bfr: Clr Aftr: Clr 
~ Readinas 1\R f\R t-.R 14 1 4 1 5 1 5 1 4 1 5 1 5 1 5 1 4 
Jmmf·mt f.R t.A fR 15 1 3 15 15 14 1 5 15 1 5 14 
ffl' ffl m 1 5 14 1 5 1 5 14 1 5 1 5 1 5 14 
Average 14.67 13.67 1 5 1 5 1 4 15 15 1 5 1 4 
lmaaeScale 1 1 1 3 2 3 2 2 2 
Clarity Scale 4+ 4+ 4+ 3- 3- 3- 3- 3-· 3- 3-• 3-· 3-· 
Order of Use 7 12 8 1 11 4 9 2 6 10 5 3 
Time 2:00 Crn. Into.· Bfr: Clr Aftr: Clr 
Read~ IIA NR IIA 13 1 3 12 14 1 5 14 1 4 14 12 
(mmHg} f\R ~ Nl 13 14 13 1 4 1 6 ( Sc t4 1 4 1 3 
Nl m f'.A 12 1 4 1 3 14 1 6 14 1 4 13 1 3 
Average 12.67 13.67 12.67 1 4 15 .67 14.33 1 4 13.67 12.67 
lmaaeScale 1 1 1 3 2 3 2 2 2 
Clarity Scale 4+ 4+ 4+ 3- 3- 3- 3- a-· a- 3-· a-· 3-· 
Order of Use 4 8 1 1 6 9 1 0 5 12 a 1 2 7 
Time 4:00 Crn. lntg,. Bfr: Clr Aftr: Clr 
Readings f\R m m 1 4 13 1 4 14 14 1 5:_ 12 1 4 1 4 
fmrnHaJ m m t.A 14 13 14 1 4 14 15 12 1 4 14 
Nl ffl m 15 13 1 5 • 1 4 1 5 1 5 13 14 1 4 
Average 14.33 1 3 14.33 14 14.a3 1 5 12.33 14 J4 
Image Scale 1 1 1 3 2 3 2 2 2 
Claritv Scale 4+ 4+ 4+ 3- 3- 3- 3- a-· 3- 3-· 3-· 3-· 
Order of Use 1 2 8 7 1 1 3 5 1 2 6 4 9 1 0 
Time 6:00 Crn. In 1a.- Bfr: Clr Aft : Clr 
Aeadinas 1\R f\R ffl 13 1 4 14 13 1a 1 4 14 1 4 1 4 
(mmHa) f\R ffl 1\R 1 3 1 2 1 4 1 4 1 3 14 14 14 1 4 
1\R f\R f\R 1a 13 . ,4 1 4 13 14 14 1 5 1 4 
Averaae 13 13 14 13.67 1 3 14 14 14.33 1 4 
Image Scale 1 1 1 3 2 3 2 2 2 
ClaritY Scale 4+ 4+ 4+ 3 ... 3 ... a .. 3- a-. a .. a .. • 3-· 3--~ 
Order of Use a 11 2 7 1 0 9 1 1 2 8 4 6 5 
DAILY AVE. 13 .67 13.3a 14 14.17 14.25 14.58 13.83 14.25 13.67 
GFn.JPAVE. 13.67 14.33 13.92 
Comments: • Two? areas .. crvstallization of g_lue _@_180 
+ OpaQue glue 360° 
Data Day 12 
I 
' 
I Date, June 1 s 1887 I 
AI..OCHl.. S(W( H202~K B.EACHSON< lti.:CX:H:L SWAB 
BiDJism No. It 112 13 111114 I • s, 18 M1 •a •a 110 '11 112 
I 
Time 1:30 Crn. rn1a.- Bfr; Clr Atw Clr 
~adlnos ~ 1\R t.R 1 1 12 14 jO 13 1.2 12 n 1 1 
tmmH~:~I Nil ~ Y-1 11 12 14 10 , a, 13 12 12 1 1 
~ 
"" 
... 1 1 12 13 10 19 14 11 12 1 , 
J.V8f8QD 1 1 12 13 &7 1 10 13 13 _11 .87 1J .67 11 
' I 
~Scale I 1 1 I _3_ 2 3 2 _2_ 2 
cratitv Stale 4+ 4+ .... 3· a .. a-- 3- a-.· a ... a-• a-• ,a .. • 
~Ord'e'roiUse 8 2 I 8 1 Q 12 4 1 e 7 5 3 11 
nnw 3:so em. lnl a.- Bfr. Clr Aftf: Clr 
Raadlnos f#i til ,.. 1 2 _lO 10 10 12 12 11 13 15 
lmmHa~ tiA ~ t.A 12 10 11 10 13 12 1 2 13 15 
1*1 ~ fiE\ 11 10 12 11 14 12 12 12 15 
Averaoe I 11.67 1 0 11 10.33 13 12 11.67 1 12.&7 l!i 
llmaae Scare t I 1 3 2 3 _2 2 2 
Clarl~ Sca!'e 4+ 4+ I 4+ 3- a- 3- :3- 3-· a- a-• .a .. •· 3 .. • 
Order of U&a 2 4 5 7 , 11 1 D , 2 3 8 9 6 
nme s:::w Crn. lnta.- Bfr: Cit Aftr: Clr 
~~ ~ ,fiR f.FI 15· _1_4 14 12 1 3 14 14 1 5 12 
(mm'Hc:~) NI:J Nl 1\R 15 1' 4 14 12 13 14 1S 18 13 
m '*11 '*I , 6 15 15 I 13 14 13 1 6 16, 13, 
Averaae I 15.33 14.33 14.33 12.33 13.33 1 3 ._&7 1 5 15.67 12.67 
l~niDB Scale 1 1 , 3 2 3 2 2 2 
Olatitv Scale 4+ 4+ 4+ s- I 3 .. s .. 3 ... s-· 3- a-• a-• a~· 
Oroer ar Use 10 6 3 4 2 5 12 g 1 7 11 8 
Time 7:30 Crn. lnla.· Bfr: C~r Ahr: Cll' I 1 .... 
.JL r.R fiR t<R 12 15 13 1 1 1 I 14 11 I 12 14 
JmmHg)_ ~ ' ~ I m: 11 15 13 12 1 I 14 1 1 1' 1 14 
~ ~ ~ '12 15 14 t2 1 2 13 1' 2 1 1 14 
Av8faae 11.67 15 19.33 11 .67 11.33 13.67 • '' ._33 n.33 14 
Lrma" scare t 1 1 3 3 3 2 2 2 
Ct;u·iiY Scare 4+ .... I . ... a .. 3- 3-. 3-
_3: -· a .. a-· a-• 3-~ 
Order of U&e 1 3 I 1 5 2 • 11 e, 
g 1 0 12 8 
I 
DAILY AVE. I 12.42 12.83 I 13.08 11.018 12.67 13.08 12.42 t2.89 13 . , 7 
G¥:ll.F .AVE I ' 12 78 U .28 12'.81 
Comments: • Two? 8feas ... c_rvstallization of glue _@_180 
+ OpaaiJ8 alue 360'-' 
' 
Data Day 13 
I I I Date June 16 1987 I I 
ALCXHJLs:w< .. 202SOAK BLEACH SOAK ALCOH1SWNJ 
BiDrism No. 
' 1 #2 #3 #4 IS 16 11 18 #9 #10 '1 1 #12 
' Tilne 3:00 Crn. In g_.- Bfr: Clr Aftr: Clr 
Readinas Nl t-El 1\R 1 2 10 11 12 1 2 12 8 1 3 9 
tmmHa) ~ ~ t.R 1 2 10 11 13 13 12 9 13 10 
~ ~ ~ 12 12 12 13 14 1 3 10 1 4 1 0 
Averaae 12 10.67 11.33 12.67 13 12.33 9 13.33 9.667 
Image Scale 1 1 1 3 2 3 2 2 2 
Clarity Scale 4+ 4+ 4+ 3 .. 3 .. 3- 3 .. 3 .. * 3 .. 3 .. • 3-· 3 .. • 
Order of Use 6 2 10 3 9 12 4 1 11 8 7 5 
Time 5:00 Crn. lntg .• Bfr: Clr Aftr: Clr 
Qeadinbs 1\R 1\R t.R 14 12 8 12 1 2 12 10 1 1 12 
fmmHa) t.R t.R t.R 1 4 12 9 13 1 2 12 1 1 1 1 12 
~ ~ t.R 13 12 1 0 14 12 12 1 0 1 1 12 
Average 13.67 12 9 1 3 12 12 10.33 11 12 
lma_g_e Scale 1 1 1 3 2 3: 2- 2 2 
Cf_crrfty Sca1e 4+ 4+ 4+ 3 .. 3 .. 3 .. 3 .. 3-· 3 .. 3 .. • 3 .. • 3 .. • 
Order of Use 9 1 0 8 4 2 7 3 1 1 12 6 1 5 
Time 7:00 Crn. lnta.· Bfr: Clr Aftr: Clr 
Readii'JQ_s 1\R t.R t.R 11 10 1 0 11 1 0 12 9 1 1 10 
CmmHal m m t-.R 11 11 10 1 1 1 0 1 2 9 1 1 9 
Nl 1\R t.R 11 1 1 10 11 1 1 12 1 0 1 1 9 
Average 1 1 10.67 10 1 1 10.33 12 9.333 1 1 9.333 
' 
lmaaeScale 1 1 1 3 2 3 2 2 2 
Clarity Scale 4+ 4+ 4+ 3 ... 3 ... 3- 3 ... 3-* 3 ... 3 ... • 3 ... • 3 .. :: 
Order of Use 8 1 1 2 7 4 1 0 9 3 11 2 5 6 
Time 9:00 Crn. lnta.- Bfr: Clr Aftr: Clr 
Readinos 1\R 1\R t.R 1 1 9 12 9 1 2 1 0 10 1 1 1 0 
fmmHa) 1\R 1\R t.R 1 0 9 12 1 0 1 2 1 0 10 1 2 1 0 
1\R t.R 1\R 1 1 & t 1 9 1 1- 1_& 10 11 1 0 
t.Average- 10.61 8.667 11.67 9.333 11.67 10 10 11.33 1 0 
lmaaeScale 1 1 1 3 2 3 2 2 2 
!Cfaritv Scale 4-+ 4+ 4+ 3 ... 3 .. 3 .. 3 .. 3 ... 3 .. 3 .. • 3-· 3 ... ; 
Order of Use 1 2 7 6 1 4 8 1 1 5 1 0 9 3 2 
OAilVAVE. 11.83 10.5 10.5 11.5 11.75 11 .58 9.6.67 11.67 10.25 
GFOJPAVE 10.94 11.61 10.53 
Comments: • T~o? areas ... crystallization of glue @180 
+ Op'aque glue 360° I I 
Data Day 14 
I I I I Date June 17 1987 I I 
N.cx::H:lls:w< H202SOAK BlEACH SOAK ALOOHOLSWNJ 
BIQrlsm No. • 1 # 2 I 13 14 ~ 15 I MA #---1-- b-- M 'a 411'!1 ... 4 .. # 1 1 #12 
-
' 
I 
lt ime 12:00 Crn. lntg.- Bfr: Clr Aftr: Clr 
Readinas f'.R f'.R ~ 14 1 4 1 5 1 7 16 1 7 15 1 5 15 
(mmHa) t-It . f'..R ~ 14 14 16 17 16 1 7 1 5 1 6 15 
f'..R f'..R ~ 14 1 4 1 7 1 8 15 1 7 14 1 6 1 6 
Aver~e 14 14 16 17.33 15.67 17 14.67 15.67 15.33 
~ 
- f--
Scale 1 1 1 3 2 3 2 2 2 
Clarity Scale 4+ 4+ 4+ a .. 3 .. a .. 3- a-· 3- 3-· 
-
3-· a-o 
Order of Use 2 6 1 0 1 1 9 4 7 1 8 12 3 5 
Time 2:00 Crn. Into.- Bfr: Clr Aftr: Clr 
Readinas t-.R t-R t*l 12 1a 13 12 13- 1~ 1:2 1 4 14 
1mmtfg} tR m m l2 12 14 1 2 13 14 12 1 3 14 
f'..R ttA ~ 12 12 14 12 1-2 14 ta 14 14 
AwutQ&.- t 2- 12".3"3" f3.67 f2 12.67 14 12.33 13.67 1 4 
Image Scale 1 1 I 1 a 2 3 2 2 2 
ClaritY Scale 4+ 4+ 4+ a- a- 3- 3- I 3-.• a .. a-· 3-· 3 .. o 
Order-ot Use- I 5 8 4 2 12 1 9 7 1 0 11 6 
Time 4:00 Crn. lnta.- Bfr: Clr Aftr: Clr 
Readil]gl; f'..R t\A ~ 1 6 1 0 12 13 12. 16 12 12 1 a 
lmtnHg) f.R f'..R t-A 1 5 11 1 2 1 3 1 2 16 1a 1a 13 
f'..R 1\R m 1 6 12 12 1 a 1a 15 12 14 1 2 
Averaae 15.67 11 12 13 12.a3 15.&7 12.aa 1 3 12.67 
In aae Scale 1 1 1 a 2 3 2 2 2 
c aritv Scale 4+ 4+ 4+ a- a- a- a .. a ... a ... a ... • a ... • 3-G 
0 dar of Use 1 1 4 1 0 9 5 12 7 6 8 a 1 2 
I 
Time 6:15 Crn. Into.· Bfr: Clr Aftr: Clr 
Readinas ~ f'..R ~ 1 4 1 4 12 1 a 1 5 14 14 1 a 1 2 
(mmHa) f'..R f\R t-R 1 5 1 4 12 1 3 L4 14 "4 13 1 2 
m . m f.R 14 14 1 3 13 15 14 14 1 3 1 3 
Averaae I 14.33 1 4 12.33 1 3 14.67 14 1 4 13 12.33 
I 
lmallEFSeale f 1 1 I 3 2 a 2 2 2 
Clarity Scale 4+ 4+ 4+ 3-- a-- 3- a-- a-. a- a--• a-· a-c 
Order of Use 9 1 1 0 2 3 8 1 2. 7 4- 5- 6 1 1 
DAILY AVE. 1 4 12.83 13.5 13.8a 1a.8a 15.17 1a.aa 1a.8a 13.53 
CHJUPAVE 13.44 14.28 13.58 
Comments: • Two? areas .. crystallization of glue @180 
+OpaQue alue 360° 
Data Day 15 
I I I Date June 18 1987 I 
ALCXlH:l. 9:>AK H202SOAK BLEACH SOAK ALOOHOI..SW/48 
BiDri$m No. ,, j2 13 
"" 
l IS 18 17 18 19 110 111 112' 
_I ~ 
Time l2:00 Crn. ln·ra.- Bfr: Clr Aht: Clr 
ReadiMS tEt I .N=t t$1 13 14 14 14 16 1. 12 14 1 3 
(mmHal ~ N=t til 13 14 14 15 16 15 1 2 14 ' 14 
t-R N1 ~ 13 14 14 1 5 1 8 15 13· 15 \5 
Averaae 13 14 14 14.67 1 8 1!4.1:17 12.93 14.33 14 
1 rmaaa Scale 1 , 1 3 3 3 2 2 2 
C~iUiCv Scala 4+ 4+ "l+ a- 3- 3 .. a- s .. • 3- 3 .. • s, ... • a-• 
Order of Usa 9 2 12 4 10 9 s 7 
' 
a 1 1 6 
liime 2:00 lem. In a.· Bfr. Clr Aftr· Clr 
Fblacinas fA ttR tfit· 14 I j_4 14 1 8 1 4 15 14 14 12 
fmmHa~ 1*1 ~ ~ 14 14 13 1 B 14 's 14 14 1.2 
tfl t-Et ~ 15 14 13 16 14 15 14 1 5 13 
Ave!'_age• ! 14.33 14 13 ,33 16 14 15 t4 114.33 12.33 
lm.age Scala 1 1 1 3 3 3 2~ 2 2 
Chul1Y Scale 4+ 4+ 4+ 3 ... s ... 3· a- 3 ... 3- 3 .. • 3 .. • a-• 
Order oS Use 12 2 6 B 3 4 1 1 0 1 1 g 5 7 
"' 
nme 4:oo Crn. In g.· Bit; Clr Aftr: Clr 
Aead"rrg_ tEl: ' ~ till 14 14 13 12 t2 13 11 10 10 
(mmlf~) 
"" 
~· N=t 14 1 3 13 13 13 13 ~2 10 1 I 
~ N=l N1 13 13 13 13 1 4 , .. 13 10 10 
Averaa.e 13.87 13.33 13 12.67 13 13.13 1 2 , 0 10 .33 
I~Scille 1 1 1 3· 3 3 2 2 2 
CflliJ'i'_ Seale ... II&+ •+ .s ... 3- a- 3-· s-· 3· a .. • a-• ' 3-· Order at Use· 12 5 3 2 11 7 1 4 8 8 1 0 9 
I 
" 
Time Cm. In fa .• Bfr. Clr Aflr. Clr 
Ra~nos Ni I m tfl 16 I 1 , u 15 1 5 15 10 12 12 
hnmHa'l ~ m ttfi 1 5 12 14 1 6 15· 1 s 1 ' 1 2 12 tE\ ~ t'<R ts 1' 2 13 1 6 14 1r 12 , 1 12 
Avera_ge 15.33 11.67 13,67 15.67 14.67' HI 11 1 11 .67 '1 2 
lJmage Seale 11 1 1 3 3 3 2 2 2 
CJJ~ri1Y Scale 4+ 4+ 4+ 3- 3 .. a~ a ... s-• 3- 3 ... 3 .. "' s .. • 
Order ol U'se 7 I 4 5 2 10 B 3 6 1 9 1 1 12 
DAILVAVE. 14.08 t3.25 I 18.5 14.75 14.42 14.75 12.33 12.58 12. 17 
GR:t.P·i..ve. _13. ·61 1 .~ .64 12.36 
Commen~ • Two? areas .. crvstallization of alue @180 
+ 0PilQU8 QIUG• 360° 
Data Day 16 
J Dare June 1 9 1987 
Bjprism _No. I I I 2 I 3 ... •511' 6 17 18 ... - 110 il11 112 
Time 11:30 Crn. ln·l~- Btr: Clr Aftr: Clr 
14 12 13 t1 12 12 , 1 10 1 1 
fmmHal 14 12 14 13 12 13 12 10 1 1 
14 Ul 14 13 13 '3 1' 2 10 12 
Ava~ , 4 12.33 13.67 12.33 12.33 12.B7 11.67 1 D 11.33 
1 1 3 3 3 _2 2_ 2 
Ctamv Seide 4 + 4 + 4+ 9- 3• I 3 .. 
Order of U&a 5 '• 8 1 2 7 1.2 j l 3 10 9 6 4 
Time 2:00 Cm.. rot a,· Bfr. Clr Aflr: Clr 
14 12 14 13 14 15 1 0 14 11 
fmmHal 13 12 14 13 14 15 10 14 12. 
13 13 13 14 14 14 13 12 
Averaoo 1·3.33 ~ 2.33 19.67 13 33 1.t.87 1 0 13.67 '11.67 
lma~Scale 1 1 1 3 3 3 2 2 2 
Clarirv Scale 4 + 4+ 4+ 3- 3- 3 ... a-· 
Ofdar al Use 6 , ' 8 9 4 1 1 3 , 2 10 5 
Time 4:30 Cm. Jntg.- BJ.r: Ctr Aftr: Clr 
11 13 12 13 14 
tmm"klf 
-"" 1' 12 13 13 1 2 14 12 12 13 
PEl 11 13 14 14 12 14 12 12 13 
Averao.e _11 12.33 13.33 13 , 2 12.33 13.33 
'1 1 1 3 3 3 1 2 2 
CtatilY Scala ~ +· 4+ 4+ 3 .. 3- 3-
Order oJ Use 4 1 , 1 2 5 7 8 3 9 10 12 6 
Time 6:00 Crn. lnta.· Bf1. Clr Ah«": err 
~ 12 12 12 14 14 14 _14 13 12 
t.R 13 12 12 14 13 14 14 12 12 
Ni f3 12 12 _1_4 14 J4 12 12 
Ava~ ,2.67 12 12 14 13.87 14 12.33 12 
lmaQaScale 1 1 1 3 3 3 t 2 2 
Cfaritv Scare <4 + 4+ 3- a ... 1 3.. 3 .. • a-
Older of Usa 1 0 2 12 7 5 4 9 3 8 , 6 
DAILY AVE. t2.75 12.25 13.17 13.17 12_._92 13.75 11.92 12.08 12 .08 
Gfp..f'AVE 1.2.?'2 13.28 .12.03 
Comments: '" Two ? il8as ... ctvslatlization of alu-e @180 
+ Opaque a.lue 3600 
Appendix 3- Figures 
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Graph of Clarity Scale Plotted as a Function of Time 
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FIGURE 3 
Graph of Image Scale Plotted as a Function of Time 
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Appendix 4- Statistical Analysis 
Correlation of Single Probe Multiple Readings 
Correlation Matrix for Variables: Xt ••• X3 
Reading 1 
Reading2 
Reading3 
ReadinG 1 
1 
.882 
.104 
Readina 2 Readina 3 
, 
.. aag 1 
Reading 1 Reeding 2 Reeding 3 
1 13 13 12 
2 12 12 12 
'· 3 14 14 14 
4 12 12 12 
5 14 14 14 
6 13 13 13 
7 13 12 13 
8 15 16 15 
9 12 13 13 
10 13 14 12 
11 15 14 15 
12 12 12 12 
13 13 14 14 
14 14 13 14 
15 13 14 14 
16 14 14 13 
17 12 13 12 
18 12 13 12 
19 13 12 13 
20 13 13 14 
21 13 13 13 
22 14 13 14 
23 13 14 14 
24 13 14 14 
25 11 12 1 1 
26 1 1 11 11 
27 1 1 10 11 
28 1 1 1 1 ' 11 
29 10 10 10 
30 12 11 12 
31 1 1 11 1 1 
32 12 12 12 
33 11 11 11 
34 11 11 10 
35 12 12 11 
36 11 11 12 
DATA DAY 1 
- - - - - - - - - - 0 N E W A Y - - - - - - - - - -
Variable V3 
Ely Variable V1 
Between Groups 
Within GrouPS 
Total 
Group Count. 
Grp 1 9 
6rp 2 9 
6rp 3 9 
Grp 4 9 
Grp S 9 
Grp 6 9 
Grp 7 9 
f~!"·;t ::~ 3 
Grp 9 9 
Grp10 9 
Grpll 9 
Grp12 9 
Tot.al 108 
RESULTS 
E:IPRISM NO 
Analysis c.•f Variance 
Sum of Mean F F 
D.F. Squares Squares Rat.io Prob. 
11 22.2963 2.0269 1. 2111 .2902 
96 160.6667 1. 6736 
107 182.9630 
Standard Standard 
Mean Deviation Error 95 Pet. Conf Int. for Mean 
12.5556 1.1304 .3768 11.6867 To 13.4244 
12.2222 1.2019 .4006 11.2984 To 13.1460 
12.7778 1.6415 .5472 11.5160 To 14.0395 
12.2222 1. 2019 .4006 ' 11.2.984 To 13.146e 
12.1111 1. 7638 .5879 10.7553 To 13.4669 
12.3333 .7071 .2357 11.7898 To 12.8769 
12.1111 .9280 .3093 11.3978 Tc• 12.8244 
. . • . ~- -.· ~ -.:1 . -~':':r:. l . S?92 . 5,):;· 1 12 . 3'355 i~:' !4 . 7l.S7 
12.2222 .9718 .3239 11.4752 Tc• 12.:%92 
12.4444 1.5092 .5031 11.2843 To 13.6045 
13.3333 1.4142 .4714 12.2463 To 14.4204 
12.3333 1.1180 .3727 11 .• 739 To 13.1927 
12.5185 1.3076 .1258 12.2691 To 12.7680 
***** Given WORKSPACE allows fc•r SS.S0 Cells wi ih 2 Dirnensic•ns for MEANS. 
-------------------------------------------------------------------------------
Pc.ge 20 SPSS/PC:+ 5117 ;c:::: 
Sul'l'•m~.ries of V3 RESULTS 
By lev&ls of Vl BIPRISM NO 
V2 TIME 
Variitble Value Label Mean St.d Dev Cases 
For Entire Population 12.5185 1.3076 108 
V1 1.00 12.5556 1.1304 9 
V2 1.00 12.6667 .5774 3 
V2 3.00 13.6667 .5774 3 
V2 5.00 11.3333 .5774 3 
Vl 2.00 12.,2222 1. 2019 9 
V2 1.00 12.0000 0.0 3 
V2 3.00 13.6667 .5774 3 
V2 5.00 11.0000 0 .0 3 
.tl 
Vl 3.00 12.7778 1.6415 9 
V2 1.00 . 14.0000 0.0 3 
V2 3.00 13.6667 .5774 3 
V2 5.00 10.6667 .5774 3 
Vl 4.00 12.2222 1.2019 9 
V2 1.00 12 .0000 0.0 3 
V2 3.00 13.6667 .5774 3 
V2 5.00 11.0000 0.0 ... ~ 
V1 5.00 12 .1111 •f' 1.7638 9 
V2 1..()0 14 .0000 0.0 3 
V2 3.00 12.3:333 .5774 3 
V2 s.ae 10.0000 0.0 3 
Vl 6.e0 12.3'333 .7071 9 
V2 1.00 13.0000 0.0 3 
V2 3.€0 12.3333 .5774 3 
V2 5.00 11.6667 .5774 3 
Vl 7.00 12.1111 .9280 9 
V2 1.00 12.6667 .5774 3 
V2 3.00 12.6667 .5774 3 
V2 5.00 11.0000 0.0 3 
Vl ::: . i)i) 1:3. s::.sE. 1 .5092 9 
V2 1.00 15.3333 .5774 3 
V2 3.(10 13.3333 .5774 3 
V2 5.00 12.0000 0.0 3 
Vl 9.00 12.2222 .9718 9 
V2 .1.00 12.6667 .5774 3 
V2 3.00 13.0000' 0.0 3 
V2 5.00 11.0000 0.0 3 
V1 10.00 12.4444 1.5092 9 
U'1 t f.:.!'.J. . ~ .... - --
Vl 11 . ':u; 1 ~: . :3:333 1 .4142 •j 
V2 1 . (.,i,1 14. E.E.67 .5774 .-·~ 
V2 3 '.•}i) l :;: . ;E. f. E. 7 . .5774 .-. . 
·-· V2 5. (t(1 11 . E·E-E-7 .&774 :?-
Vl 12. ·~(i 12 . ::. 3~:::3 1 11 ::;\) 9 
V2 l 
. '~") 12. (;(,00 (i. t' :3 
'r ·;: . (;i;) 1:3. £.6E·7 .5774 ·:· .. .... 
V2 S.~~ 11 . 3:3:;~.3 .5774 ·j 
·-· 
------~------------------------------------------------------------------------
Group 
Gr~· 1 
Grp 2 
Grp 3 
Grp 4 
Grp 5 
Grp 6 
Grp 7 
Grp 8 
Grp 9 
Grp10 
Grpll 
Grp12 
Minirnum 
11. Ot1l)(1 
11. OG0i} 
10 . (1(11)1~ 
11.0000 
10. (100,) 
11.0000 
11 . 000i; 
12.0000 
11.0000 
10.0000 
11.0000 
11. 000(., 
Maximum 
14 .0(100 
14.0000 
14 .0t100 
14.0000 
14.0000 
13.0000 
13. 00€") 
16.0000 
13.0000 
14.0000 
15.0000 
14.0000 
Cocl".nns C = Max. Variance/Sum<Voric.nces) = 
Bartlet.t.-Box F = 
Maximum \'arionce I t1inimurt• Variance 
.1549, p = 
. 981 1 p : 
6.222 
.642 (Approx.) 
.4€.1 
T-Test of time 0 Order Data 
· Unpaired t-Teat X1: Order Y1 : Reading a 
OF: 
11.322 
Unpaired t Value: 
1.195 
Prob. (2-tall): 
G roM~) : c ount: Mean: Sd 0 t . av.: td. S E rror: 
E 18 12.889 1.711 .403 
L 18 12.278 .958 .226 
Readings Order 
1 15 E 
2 16 E 
3 15 E 
4 12 E 
5 13 E 
6 12 E 
7 11 E 
8 12 E 
9 1 1 E 
10 14 E 
11 4 E 
12 4 E 
13 4 E 
14 3 E 
15 4 E 
16 1 E 
17 1 E 
18 0 E 
19 3 L 
20 2 L 
21 3 L 
22 3 L 
23 4 L 
24 14 L 
25 13 L 
26 1 1 L 
27 12 L 
28 12 L 
29 12 L 
30 12 L 
31 12 L 
~2 13 L 
33 12 L 
34 11 L 
35 11 L 
36 11 L 
1 factor ANOVA of probe daily averages 
One Factor ANOVA X1: Groups Y1: Readings 
Analysis of Variance Table 
Source: OF: Sum SQuares: Mean SQuare: F-test: 
Between arouPS 2 9.432 4.716 3.753 
Within aroups 141 177.195 1.257 .R_ •• 0258 
Total 143 186.626 
Model II estimate of between component variance • 1. 73 
One Factor ANOVA X1: Groups Y1: Readings 
G roup: c ount: M ean: Sd 0 t . ev.: Std E rror: 
H202 48 12.526 1.025 :148 
Bleach 48 12.973 1.25 .18 
Swab 48 12.369 1.076 .155 
One Factor ANOVA X1: Groups Y1: Readings 
c ompanson: Mean Oiff.: Fisher PLSD: Scheffe F-test: Dunnett t: 
H202 vs. Bleach ·.447 .452 1.91 1.955 
H202 vs. Swab .157 .452 .235 .685 
Bleach vs. Swab .604 .452* 3.484* 2.64 
* Significant at 95% 
Reedings Groups 
-v1 -x1-
1 12.22 H202 
2 12.67 H202 
3 11.25 H202 
4 10.42 H202 
5 12.58 H202 
6 11.67 - H202 
7 14.00 H202 
8 12.33 H202 
9 12.92 H202 
10 12.42 H202 
1 1 13.67 H202 
12 12.42 H202 
13 11.83 H202 
14 14.00 H202 
15 14.08 H202 
16 12.75 H202 
17 12.11 H202 
18 11.50 H202 
19 12.00 H202 
20 10.08 H202 
21 12.58 H202 
22 12.08 H202 
23 14.25 H202 
24 12.83 H202 
25 12.58 H202 
26 11.75 H202 
27 13.33 H202 
28 12.83 H202 
29 10.50 H202 
30 12.83 H202 
31 13.25 H202 
32 12.25 H202 
33 12.33 H202 
34 12.92 H202 
35 12.08 H202 
36 11.00 H202 
~7 12.08 H202 
~8 11.83 H202 
39 14.25 H202 
40 13.67 H202 
Readings Groups 
_ v, 
-x, _ 
41 12.42 H202 
42 12.92 H202 
43 14.00 H202 
44 13.08 H202 
45 10.50 H202 
46 13.50 H202 
47 13.50 H202 
48 13.17 H202 
49 12.11 Bleach 
50 13.08 Bleach 
51 11.92 Bleach 
52 10.25 Bleach 
53 12.50 Bleach 
54 11.08 Bleach 
55 13.75 Bleach 
56 14.58 Bleach 
57 12.83 Bleach 
58 12.75 Bleach 
59 14.17 Bleach 
60 11.08 Bleach 
61 11.50 ' Bleach 
62 13.83 Bleach 
63 14.75 Bleach 
64 13.17 Bleach 
65 13.56 Bleach 
66 11.33 Bleach 
67 11.58 Bleach 
68 10.75 Bleach 
69 12.83 Bleach 
70 12.25 Bleach 
71 14.83 Bleach 
72 13.17 Bleach 
73 14.25 Bleach 
74 12.92 Bleach 
75 14.25 Bleach 
76 12.67 Bleach 
11 11.75 Bleach 
78 13.83 Bleach 
79 14.42 Bleach 
80 12.92 Bleach 
Reedings Groups 
Y1 -x1-
81 12.22 Bleach 
82 12.75 Bleach 
83 12.83 Bleach 
84 10.83 Bleach 
85 12.17 Bleach 
86 12.25 Bleach 
87 14.50 Bleach 
88 14.08 Bleach 
89 13.67 Bleoch 
90 13.83 Bleoch , 
91 14.58 Bleach 
92 13.08 Bleach 
93 11.58 Bleach 
94 15.17 Bleech 
95 14.75 ' Bleech 
96 13.75 Bleech 
97 12.44 Swab 
98 12.58 swab 
99 12.00 Swab 
100 10.33 Swab 
101 11.58 Swab 
102 11.50 Swab 
103 13.50 Swab 
104 12.83 Swab 
105 13.08 Swab 
106 12.08 sweb 
107 13.83 Swab 
108 12.42 Swab 
109 9.67 Swab 
110 13.33 Sweb 
1 1 1 12.33 Swab 
112 11.92 Swab 
113 13.33 swab 
114 12.92 swab 
115 12.00 swob 
116 10.42 Swob 
117 11.58 Swab 
118 10.83 Swob 
119 12.83 Swab 
120 12.17 swab 
Reedings Groups 
-v, -x,_ 
121 12.50 Swab 
122 13.42 .Swab 
123 14.25 Swab 
124 12.83 SW8b 
125 11.67 sweb 
126 13.83 SWDb 
127 12.58 Swab 
128 12.08 Swob 
129 12.33 SW8b 
130 12.92 Swob 
131 12.67 Swab 
132 10.17 Swab 
133 11.67 Swab 
134 11.25 Swab 
135 13.67 Swab 
136 12.50 Swab 
137 13.17 Swab 
138 14.08 Swab 
139 13.67 Swab 
140 13.17 Swab 
141 10.25 Swob 
142 13.28 Swob 
143 12.17 Swob 
144 12.08 Swab 
Mann-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groups Y1: Readings 
Number: l: Rank: Mean Rank: 
Alcohol I:: 1340 121.25 I Bleach 188 11.75 
u 52 
U-prlme 204 
z -2.864 
Z corrected for ties -2.997 
# tied aroups 3 
Mann:-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groupa Y1: Readings 
Alcohol 
Swab 
u 
U-prime 
z 
Z corrected for ties 
# tied groups 
Number: 
16 
16 
r Rank: 
340 
188 
52 
204 
·2.864 
-2.983 
3 
Mean Rank: 
21.25 
11.75 
Mann-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groupa Y1: Readings 
H202 
Bleach 
u 
U-prime 
z 
Z corrected for ties 
# tied Qrou_ps 
Number: 
16 
16 
I: Rank: 
260.5 
267.5 
124.5 
131.5 
-.132 
·.149 
2 
Mean Rank: 
16.281 
16.719 
Mann-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groups Y1: Reading• 
Number: I Rank: Mean Rank: 
Bleach I:: 1269.5 116.844 ! Swab 258.5 16.156 
u 122.5 
U-prime 133.5 
z ·.207 
Z corrected for ties ·.234 
# tied groups 2 
Mann-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groups Y1: Readings 
H202 
Swab 
u 
U-prlme 
z 
Z corrected for ties 
# tied groups 
Number: 
I:: 
! Rank: 
127 
129 
-.038 
-.042 
4 
Mean Rank: 
118.562 
16.438 
Mann-Whitney U test of Clarity Scale 
Mann-Whitney U X1: Groups Y1: Readings 
Alcohol 
H202 
u 
U-prime 
z 
Z corrected for ties 
# tied groups 
Number: 
I:: 
l:Rank: 
188.5 
52.5 
203.5 
-2.846 
-2.964 
4 
Mean Rank: 
11.781 
Reo dings Groups 
1 1.00 Alcohol 
2 1.00 Alcohol 
3 1.08 Alcohol 
4 2.25 Alcohol 
5 4.00 Alcohol 
6 4.00 Alcohol 
7 4.00 Alcohol 
8 4.00 Alcohol 
9 4.00 Rlcohol 
10 4.00 Rlcohol 
11 4.00 Alcohol 
12 4.00 Alcohol 
13 4.00 Alcohol 
14 4.00 Alcohol 
15 4.00 Alcohol 
16 4.00 Rlcohol 
17 1.00 H202 
18 1.00 H202 
19 1.00 H202 
20 1.50 H202 
21 1.92 H202 
22 2.25 H202 
23 2.92 H202 
24 3.00 H202 
25 3.00 H202 
26 3.00 H202 
27 3.00 H202 
28 3.00 H202 
29 3.00 H202 
30 3.00 H202 
31 3.00 H202 
32 3.00 H202 
33 1.00 Bleach 
34 1.00 Bleach 
35 1.00 Bleach 
36 1.42 Bleach 
371 1.75 Bleech 
38· 2.08 Bleach 
39 3.00 Bleach 
40 3.00 Bleach 
Readings Groups 
41 3.00 Ble8ch 
42 3.00 Bleach 
43 3.00 Bleach 
44 3.00 Bleach 
45 3.00 Bleach 
46 3.00 Bleach 
47 3.00 Bleach 
48 3.00 Bleoch 
49 1.00 SW8b 
50 1.00 Swab 
51 1.00 Swab 
52 1.50 Swab 
53 1.67 swab 
54 2.00 SW8b 
55 2.92 Swab 
56 3.00 swob 
57 3.00 swab 
58 3.00 Swab 
59 3.00 SW8b 
60 3.00 swab 
61 3.00 SW8b 
62 3.00 SI..\.'Bb 
63 3.00 SW8b 
64 3.00 Swob 
Mann-Whitney U test of Image Scale 
Mann-Whitney U X1: Group Y1: Reading 
H202 
Bleach 
u 
U-prime 
z 
Z corrected for ties 
I tied groups 
Number: 
1:: 
I: Rank: 
28 
228 
·3. 769 
·4.091 
5 
Mean Rank: 
22.75 
Mann-Whitney U test of Image Scale 
' 
Mann-Whitney U X1: Group Y1: Reading 
Bleach 
Swab 
u 
U-prime 
z 
Z corrected for ties 
tl tied aroups 
Number: l: Rank: 
1:: 
82 
174 
·1.734 
·1. 771 
7 
Mean Rank: 
119.375 
13.625 
Mann-Whitney U test of Image Scale 
Mann-Whitney U X1: Group Y1: Reading 
H202 
Swab 
u 
U-prlme 
z 
Z corrected for ties 
' # tied grOUJ)S 
Number: r. Rank: 
16 172 
16 356 
36 
220 
-3.467 
-3.861 
4 
Mean Rank: 
10.75 
22.25 
Reading Group 
1 1.00 H202 
2 1.00 H202 
3 1.00 H202 
4 1.00 H202 
5 1.00 H202 
6 1.08 H202 
1 1.08 H202 
8 1.00 H202 
9 1.00 H202 
10 1.00 H202 
1 1 1.00 H202 
12 1.00 H202 
13 1.00 H202 
14 1.00 H202 
15 1.00 H202 
16 1.00 H202 
17 1.00 Bleach 
18 1.00 Bleach 
19 1.00 Ble8Ch 
20 1.08 Ble8ch 
21 1.92 Ble8Ch 
22 1.75 Bleach 
23 2.00 Bleach 
24 2.00 Bleach 
25 2.92 Bleach 
26 2 .. 50 Bleach 
27 2.67 Bleach 
28 2.75 Bleach 
29 2.67 Bleach 
30 2.67 Ble8ch 
31 3.00 Ble8Ch 
32 3.00 Bleach 
33 1.00 SW8b 
34 1.00 Swab 
35 1.00 SW8b 
36 1.00 SW8b 
~7 1.92 Swab 
3'8 1.83 SW8b · 
39 1.75 swab 
40 2.00 SW8b 
Reeding Group 
41 2.00 Swab 
42 2.00 Swab 
43 2.00 Swab 
44 2.00 Swab 
45 2.00 swab 
46 2.00 swab 
47 2.00 Swab 
48 1.83 Swab 
Appendix 5-lnformed Consent Form 
Informed Consent Form 
1) Institution 
A. Title of project: "The Effect of Disinfection Solutions on Goldmann Tonometer Blprisms• 
B. Principal Investigator: Nada J. Ungel, 0.0. Phone: 359-5641 
C. Advisor: Bradley Coffey, O.D. Phone: 357-6151 ext. 2280 
D. Location: PacifiC University College of Optometry 
Forest Grove, Oregon 97116 
E. Date: 22 May 87. 
2) Description gf Project 
This project is designed to determine what effect(s). If any. three different CDC 
recommended methods for disinfection against the AIDS virus have on the structural integrity 
of the Goldmann tonometer biprism. This will be determined by: a) visually Inspecting the 
blprisms under magnification, and b) comparing the readings obtained from the blprisms 
disinfected by. these means with those cleaned in the routine manner. 
In the procedure, I will inspect each blprism to be used on your eye with a biomicroscope to 
make sure it is smooth and safe. A· topical anesthetic and dye will be Instilled Into your eye 
for your comfort during the procedure, and I will then measure the pressure Inside of your 
eye with the Goldmann tonometer, a standard optometric instrument and routine. Several 
readings will be taken with each biprism to assure accuracy of measurement. 
At the conclusion of these measurements, a thorough evaluation of the health of your eye will 
be provided, and you wiH be free to leave. 
3) Description gf Risks 
Participants in this study may experience corneal abrasion, and/or allergic reaction to the 
diagnostic agent utilized (Fiuress). Both of these infrequent but possible complications clear 
up without treatment within 24 hours. 
4) Description of Benefits 
This study will serve to determine the safest method of disinfecting ophthalmic equipment 
against the AIDS virus. This Increased knowledge will serve to better protect the public 
against the possible spread of the virus from routine optometric procedures. 
5) Compensation aQd Medjcal Care 
If you are Injured In this experiment It Is possible that you will not receive compensation of 
medical care from Pacific University, the experimenter, or any organization associated with 
the experiment. All responsible care will be used to prevent Injury, however. 
6) Abernatives A<tvantageoys to Sybiftcts 
Not applicable. 
7) Offer to Answer Any lngytdes 
The experimenter will be happy to answer any questions that you may have at any time 
during the course of the study. If you are not satisfied with the answers you receive, please 
call Dr. James Peterson at 357-0442. During your participation In the project you are not 
a clinic patient for the purposes of the research, and all questiofns should be directed to the 
researcher and/or the faculty advisor who wm be soley responsible for any treatment 
(except for an emergency). 
8) Freedom to WJthdcaw 
You are free to withdraw your consent and discontinue participation In this project or 
activity at any time without prejudice to you. 
9) Coofldeotjallty of Records 
All informaJion collected will be treated as confidential. Publication of resultS will involve 
only grouped data or individual data in which you are identified only by · initials or random 
code number. 
Consent Form 
I have read and understand the above. I am 18 years of age or over. 
PRINTED NAME. _____________________________ AGE. ______ __ 
SIGNED DATE. __ _ 
ADDRESS ___________________________ PHONE. _________ _ 
CITY _________________ STATE/ZIP __________ _ 
NAME AND ADDRESS OF A PERSON NOT UVING WITH YOU WHO WILL ALWAYS KNOW YOUR 
ADDRESS: 
·------·-----------·------------
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